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 MicroRNAs constitute a vital new component of our evolving 
understanding of regulatory mechanisms that shape cellular gene expression. As 
ubiquitous regulators of protein translation, microRNAs have a unique 
regulatory function that is only beginning to be fully described. In addition, their 
role in the control of gene expression in neurons, which underpins neuronal 
identity and information processing, has not been fully addressed. 
 In this thesis, I present studies that demonstrate a potent yet previously 
unknown regulation of neuronal intrinsic excitability by the microRNA miR-128. 
I show using genetic models that endogenous miR-128 plays a powerful role in 
dampening the excitability of pyramidal projection neurons in the adult 
forebrain and demonstrate that the loss of this microRNA alone results in severe 
motor hyperactivity and fatal epilepsy. By employing genetic tools that permit 
the interrogation of miR-128-mediated repression and its downstream 
physiological effects in restricted neuronal populations, I show that miR-128 
exerts a sensitive tuning control of target gene expression, intracellular signaling 
cascades activation and behavioral measures of excitability. 
 The work presented here will help to guide future studies of microRNA 
function in neurons and other cell types, and reveals a small RNA and its target 
network as a novel regulatory node with possible implications in animal 
behavior and human pathology. 
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Chapter 1: Introduction 
 2 
 In complex multicellular organisms, terminally differentiated somatic cells 
are participants in a vast division of labor. These cells perform specialized tasks 
that enhance the survivability and the fitness of the organism as a whole. The 
role of most if not all of these cells can be simplified as follows:  
1. Taking a measure of their environment by probing and measuring the 
presence of external signals such as photons, pressure, metabolites, 
neurotransmitters etc.  
2. Responding to the combination of these inputs by changing their own internal 
environment, producing a response that can be read by other cells and for some 
cells issuing a response that alters the great Exterior itself.  
3. Employing homeostatic control to ensure their ability to respond to further 
inputs in a consistent manner. 
 For neurons of the central nervous system, the role is similar if somewhat 
more elaborate. While the input is composed mostly of membrane potential 
changes, chemical neurotransmitters and neuropeptides, the range of responses 
is vast. Firstly, neurons integrate multiple inputs across the dendritic network to 
transform input information. Secondly, neurons often engage cytoplasmic and 
nuclear plasticity mechanisms to change their response to future inputs. Finally, 
neurons require homeostatic controls that preserve not only their ability to 
respond to further inputs, but also their capacity to re-engage plasticity 
mechanisms to set down new and persistent changes. 
 In addition to the internal complexity of the singular neuron, the adult 
brain of mammals consists of a daunting diversity of functionally unique 
neuronal subsets. Cell types are characterized by stereotyped morphology, 
regional and laminar location, connectivity and neurotransmitter output and 
 3 
receptivity. The reductionist approach to neuroscience, which has proven 
enormously useful in explaining animal behavior, requires careful accounting of 
neuronal diversity as well as an understanding of how information is processed 
in each subtype.  
 Both the neuronal identity and response profiles exhibited by each 
neuronal subtype are greatly influenced by gene expression. The combination of 
genes expressed, the quantity to which they are produced, the temporal pattern 
and spatial localization of their expression, are all salient factors. It is not 
surprising then that neuronal gene expression is regulated at multiple levels - 
epigenetic, transcriptional, post-transcriptional and translational, each conferring 
a unique regulatory function.  
 Among the post-transcriptional mechanisms discovered so far, a class of 
small non-coding RNAs known as microRNA (miRNAs) has drawn particular 
interest among neuroscientists. There exists a large number of unique miRNAs 
many of which are expressed in the brain and exhibit neuronal subtype specific 
expression patterns. This suggests a role in determining identity and/or shaping 
cell-type specific processes, but only a handful of neuronal miRNAs have been 
studied so far. 
 The work I present in this thesis aims to examine the functional 
consequences of miRNA expression in neurons. It will examine the manner in 
which miRNAs alter gene expression and affect physiology and information 
processing in specific neuronal subsets. More generally, the results presented 
here will improve our understanding of the multi-layered architecture of gene 
expression in neurons and other cells.
 4 
 In this introduction, I will briefly review the original discovery of the 
miRNA system, outline the current understanding of miRNA biogenesis and 
function, discuss key miRNA regulatory motifs, and review current knowledge 
of miRNA function in neurons.  
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1.1 microRNAs: a novel small RNA family 
 The compendium of genetically encoded small noncoding RNAs in 
animals encompasses a growing list of unique classes, including piwi-interacting 
RNAs (piRNAs) (1) , pseudogene derived endogenous siRNAs (endo-siRNAs) 
(2), and microRNAs (miRNAs). Among these, miRNAs represent arguably the 
most ubiquitously expressed class of small RNAs, as well as the most intensely 
studied.  
 The first miRNAs let-7 and lin-4 were discovered in nematode worms (C. 
elegans) as a result of genetic screens for novel heterochronic genes. let-7 and lin-4 
were found to regulate the timing of larval cell fate decisions, by repressing 
translation of protein-coding messenger RNAs (3-5), demonstrating in animals a 
unique form of small-RNA mediated post-transcriptional regulation. 
 Soon after, studies showed that miRNAs were more than simply an 
esoteric innovation of invertebrate evolution. The broad conservation of let-7 
throughout bilateran lineages and the detection of let-7 and other novel miRNAs 
in a wide range of eukaryotic cells revealed miRNAs to be part of an ancient and 
ubiquitous regulatory mechanism (6-10). These efforts in addition to deep 
sequencing studies have identified hundreds of miRNAs in humans and mice, 
including both highly conserved miRNA families as well as species-specific 
members (11-13). The latest update in miRBase (www.mirbase.org), a 
comprehensive miRNA database, lists over 1200 miRNAs and over 2000 
miRNAs in the mouse and human genomes respectively.
 6 
 The discovery of miRNAs was contemporaneous with the seminal 
discovery of RNA interference (RNAi), a post-transcriptional sequence-specific 
mechanism of gene silencing through exogenous introduction of double stranded 
RNA (dsRNA) (14).  
 Starting with double stranded RNA, RNAi involves small interfering 
RNA (siRNA) intermediates of 22-26 nucleotide length, which mediate 
degradation of transcripts with complementary sequences. Sequence analysis of 
miRNA loci and biochemical isolation of miRNA intermediates revealed that 
miRNA production also involved a double stranded precursor in the form of a 
hairpin structure. These structural parallels between siRNA and miRNA 
immediately suggested the possibility of common mechanisms of biogenesis. 
Mechanistic links between the two were formally demonstrated by a common 
requirement for Dicer and Argonaute family proteins (15-18). Other steps 
required for the maturation of functional miRNA, from transcription to 
incorporation into effector complexes, were discovered soon after.  The canonical 
pathway of miRNA production in mammalian cells that evolved as a result is 
outlined below. 
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1.2 Biogenesis and decay 
 miRNA loci are distributed in multiple locations across the genome. 
About half of these loci are located in intergenic regions and have unique cis-
regulatory sequences such as enhancers and promoters (19).  Other miRNAs are 
located in the introns of protein coding genes and are generally co-expressed 
with their host genes.  In both cases, miRNAs can occur either singly or as one of 
many in a poly-cistronic cluster, with multiple hairpins located on one 
continuous primary RNA transcript (pri-miRNA). 
 Systematic studies of expression patterns of miRNAs and host genes show 
strong co-expression between closely spaced miRNAs and between intronic 
miRNAs and their host genes (20). This could result from their expression from a 
single transcript, or simply reflect the existence of common cis-regulatory 
regions. Like protein-coding mRNA, the vast majority of pri-miRNAs are 
transcribed by RNA polymerase II (Pol II) (21, 22), although RNA polymerase III 
(Pol III) promoters have been detected in association with some miRNAs (23, 24), 
and are likely to support higher transcription rates at these loci. 
 Regardless of their genomic location, further processing of miRNAs 
requires the formation of a hairpin structure called the precursor miRNA (pre-
miRNA), which includes an imperfectly complementary double stranded stem 
and a terminal loop. The mature miRNAs are derived from one or both strands 
of the stem region.  Pre-miRNAs are processed from pri-miRNA co-
transcriptionally by the nuclear Microprocessor complex (25). This complex 
consists of two core-proteins: DGCR8, which binds to the hairpin stem loop and 
Drosha, which catalyzes the cleavage of the pre-miRNA from the rest of the 
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transcript (26, 27). For intronic miRNAs, precursor cleavage occurs after the 
assembly of exon-junction complexes but before excision of introns (28), ensuring 
that accurate mRNA splicing can occur despite the presence of intronic miRNAs. 
 Pre-miRNAs are exported to the cytoplasm by the GTP-dependent 
karyopherin protein Exportin5 to be processed and incorporated into the RNA-
induced silencing complex (RISC).  Pre-miRNAs are processed by the RISC-
loading complex (RLC), which consists of 3 core proteins - Dicer, TRBP and 
Argonaute (Ago) (29). Dicer catalyzes a second cleavage step to generate a 
double stranded intermediate analogous to siRNAs. This miRNA/miRNA* 
duplex is then loaded onto Argonaute, the core miRNA-mRNA binding subunit. 
Selection of the effective strand of the duplex is thought to be a stochastic process 
with strand use bias determined by the relative thermodynamic stability of the 5' 
ends (30, 31). Finally, Ago catalyzes the unwinding of the duplex in an 
endonuclease-independent mechanism (32-34) to complete the miRNA 
maturation process. 
 Major deviations from the above canonical pathway (Figure 1) for miRNA 
production have been shown to exist in mammals, however these cases are 
extremely rare. Drosha-independent processing has been demonstrated for a 
subclass of miRNAs called mirtrons in which short intronic miRNA hairpins are 
excised from pri-miRNA using components of the splicing machinery (35, 36). 
Furthermore, it was demonstrated recently that processing of the mammalian 
miRNA miR-451 is Dicer-independent. Instead, pre-miR-451 cleavage requires 
Ago2 endonuclease activity (37-39). 
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Figure 1. Canonical biogenesis of miRNA 
 
Figure 1 Canonical biogenesis of miRNA. 
Pol II transcribes most intronic and intergenic miRNAs into pri-miRNA 
transcripts, which may contain one or multiple hairpins. Pre-miRNA hairpins are 
cleaved from pri-miRNAs by the Microprocessor complex, and are exported 
from the nucleus by Exportin5. Pre-miRNAs are further cleaved and unwound 
by RLC. Finally, mature single stranded miRNAs are loaded into Argonaute-
containing RISC complexes.
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 Unlike miRNA biogenesis, relatively little is known about the regulation 
of miRNA degradation. Experiments that track the loss of mature miRNAs upon 
Dicer deletion in vivo and in cell culture suggest that miRNAs can be very long-
lived. Variation in stability between miRNAs can be substantial. For example, 
Dicer deletion in mature Purkinje cells of the cerebellum resulted in complete 
absence of miR-124a at the earliest observation time point (2 weeks after 
deletion), but other miRNAs appear to persist for weeks (40). Measurements of 
miRNA decay rates upon Dicer deletion in mammalian fibroblast culture 
produced an estimated average half-life of 5 days but with substantial variation 
between miRNAs (41).  
 Other studies however have shown that miRNA stability is strongly 
dependent on cellular state, and in some cases turnover can be very rapid. 
miRNAs appear to have higher decay rates in cycling cells and greater stability 
upon mitotic arrest. Interestingly, decay in neurons appears to be activity-
dependent. Glutamate-induced neuronal activation enhances miRNA decay, 
such that most expressed miRNAs have high turnover rates in hippocampus and 
cortical neurons (42).  
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1.3 miRNA target binding 
 The RISC complex with a single stranded 19-22 nucleotide mature miRNA 
is the primary effector complex in miRNA-mediated post-transcriptional 
repression. miRNAs serve as guide strands for RISC complexes, allowing 
binding to target mRNAs through partial sequence complementarity.  
 This partial complementarity between miRNA and target has been 
dissected to reveal the structural factors that contribute to functional binding. 
miRNA bases 2-7 from the 5' end define the minimal seed sequence, and perfect 
complementarity between the seed and target mRNA is the most important 
criteria for effective binding (43-45). Imperfect complementarity outside of the 
seed region may contribute to binding efficiency, but the effect is small and only 
in rare cases do such binding compensate for the lack of perfect seed 
complementarity. This requirement of seed binding has since been validated by 
structural studies (46-49). The major contribution of the seed sequence to target 
specificity has led to the classification of miRNAs into related families in which 
miRNAs share identical or highly similar seed sequences and are therefore likely 
to have highly overlapping target sets. 
 In addition, RISC binding is influenced by the context of the target site 
within the transcript. Repression is favored by the following structural factors 
that reduce physical occlusion of RISC-binding and improve accessibility of 
secondary structures: (i) Target site location in the 3'UTR as opposed to coding 
region or 5'UTR. (50, 51) (ii) Location of seed site within the beginning and end of 
3'UTR of mRNA (52, 53), and (iii) Uracil and adenosine rich context of the seed 
(53-55). Lastly, most transcripts contain many potential miRNA target sites, and 
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often multiple target sites for one miRNA.   
 Binding of a single transcript by multiple RISC-complexes unsurprisingly 
increases the repressive effect. Biochemical analysis reveals that while most of 
these interactions occur in an independent and non-cooperative manner (53, 55), 
sites spaced between 13-35 nucleotides apart result in cooperative repression (53, 
56, 57). 
 The specific sequence requirements of seed complementarity and other 
sequence-based determinants of miRNA binding have encouraged a 
proliferation of prediction algorithms to identify targets in-silico. In addition to 
combinations of the above factors, many of these programs employ measures of 
site conservation to improve selectivity for biologically functional sites. 
Furthermore, most algorithms attempt to rank predictions based on scores 
generated for some of the above factors as well as others such as predicted 
miRNA-target pairing stability.  
 The resulting lists of predicted targets are largely overlapping due to the 
requirement of seed pairing but contain important differences related to 
variations in weighting factors, and the use of different transcript databases. 
Recent studies that rate the performances of these algorithms against 
experimental data largely demonstrate a significant but weak correlation even 
for the best performing algorithms, with false positive rates exceeding 50% (58). 
Such a result is perhaps unsurprising given that the algorithms employ only 
general targeting principles, most of which were derived from cell culture 
experiments involving highly expressed miRNAs. 
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 Among the other factors that remain unaccounted for in most predictive 
algorithms, I will highlight three salient ones here. Firstly, many RNA-binding 
proteins regulate transcript localization and stability. How and if these proteins 
interact with RISC complexes is still largely unexplored. Secondly, cell-type 
specific expression of miRNAs and mRNAs can result in large variations in 
miRNA-target ratios and differing combinations of miRNAs available to target a 
given transcript. Finally, the mechanisms mediating miRNA-dependent 
repression (e.g. stability of translationally repressed transcripts) may be species 
and cell-type specific. As such the degree of repression experimentally observed 
will depend on the way in which miRNA levels were perturbed and the manner 
in which these observations were taken, e.g. protein versus mRNA 
quantification. 
 Given the limited utility of predicted targets in light of these factors, 
recent studies have tried to identify in-vivo interactions by isolating RISC 
complexes and their associated RNA (59, 60). These early studies also had limited 
success due the an apparent promiscuity of miRNA-transcript interactions. 
Subsequent iterations have improved the specificity and reduced false positive 
rate.  
 One such example (HITS-CLIP) uses UV-crosslinking of Ago to bound 
RNA followed by isolation and sequencing of bound mRNA (61, 62). The 
authors' own comparison with genome-wide protein quantification of miRNA 
repression suggests an improvement of false positive rate to ~30%. The technique 
was applied to identify miRNA targets in embryonic stem cells and in neurons 
(61, 63). This technique however is limited by the low efficiency of UV-
crosslinking and low RNA yield. 
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 An alternative technique (PAR-CLIP) uses a photo-activatable nucleoside 
to facilitate the formation of mRNA-Ago covalent links. This technique also 
permits subsequent identification of the cross-linked nucleotide and therefore 
allows the exact Ago-RNA binding site on the transcript to be readily identified 
(64). The major limitation with this protocol is the requirement for synthetic 
nucleosides, which limits its application to cultured cells. 
 Finally, even the presence of Ago-miRNA-mRNA association in-vivo does 
not in itself imply target repression. At least one experimental comparison 
between mRNA target repression and target association using both HITS-CLIP 
and PAR-CLIP has been performed (65). The results suggest that while both 
CLIP techniques show good agreement, and outperformed most predictive 
algorithms, only 50% of predicted targets were repressed by exogenously 
applied miRNA.  
 In conclusion, substantial progress has been made in elucidating the basic 
determinants of miRNA-target pairing but transcript and cell specific 
determinants are not readily accounted for. New tools like HITS-CLIP and PAR-
CLIP permit unbiased discovery of physiological miRNA-target interactions, 
however, only subsets of these interactions result in target repression, implying 
the need for independent assessments of target repression. 
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1.4 microRNA-mediated repression  
 In the vast majority of cases, miRNA-RISC binding results in 
downregulation of the target gene through translational repression and/or 
mRNA deadenylation and degradation (Figure 2). Extensive complementarity 
between miRNA and target RNA can result in Ago2-dependent endonucleolytic 
cleavage and degradation of the target as in RNAi (66) but this is rarely observed 
in animals.  
 Initial analysis of translation repression suggests that miRNA repression 
did not result in changes in polysome distribution of the target mRNA and that 
repression occurred at a post-initiation step, likely by stimulating ribosome drop 
off during polypeptide elongation (67, 68). Subsequent studies however, have 
provided heavy evidence in favor of inhibition of translational initiation as a 
major mechanism of repression. Firstly, endogenous mRNA targets shift to 
lighter polysome fractions upon miRNA-repression (69, 70). Secondly, 5' m7G 
cap-independent translation is not subject to miRNA repression (71, 72). 
Furthermore, in vitro reconstituted translation experiments have also 
demonstrated the importance of initiation mechanisms involving the mRNA 5' 
m7G cap (72-74). Finally, structural studies show that the Mid domain of 
Argonaute proteins can bind directly to the 5' m7G cap (75). 
 Although miRNAs were initially thought to regulate translation with 
minimal effect on mRNA level, many subsequent microarray and reporter 
construct experiments show that target silencing is accompanied by mRNA 
degradation. The consensus mechanism for this involves Ago binding of GW182 
and PABP which in turn recruits decapping and deadenylase enzymes to initiate
 16 
 
 
 
 
 
Figure 2. Modes of miRNA repression 
 
Figure 2. Modes of miRNA repression. 
RISC binding to 3' untranslated region of messenger RNAs results in protein 
output repression by two non-mutually exclusive mechanisms. Argonaute 
proteins block translational initiation possibly by binding 5' cap structure and 
blocking recruitment of cap-dependent initiation factors. Argonaute also recruits 
decapping and de-adenylation enzymes via GW182 proteins to initiate mRNA 
degradation.
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mRNA decay (76, 77). It remains unresolved whether translational inhibition and 
mRNA degradation are mechanistically coupled or independent. Based on 
kinetic experiments, it appears that inhibition of initiation occurs more rapidly 
than mRNA decay, suggesting that the former precedes and perhaps triggers the 
latter. As mRNA 3'UTRs also contain other cis-regulatory sequences that may 
recruit other RNA-binding factors, it is also likely that the relative contribution of 
inhibition and decay to the overall steady state repression is transcript and 
context specific. 
 More recently, genome-wide studies have sought to address this issue by 
quantifying concurrent changes in protein output, mRNA-ribosome association 
and mRNA level upon exogenous miRNA perturbation (58, 78-80). These studies 
indicate a strong correlation between changes in protein and mRNA levels. They 
also show that the repression of protein output is mildly but consistently higher 
than that of mRNA reductions, demonstrating that mRNA decay is a major 
component of repression but insufficient to account for miRNA effects alone. The 
result of these studies also confirms what had been observed with microarray-
based quantification of target mRNAs. miRNA repression produces very mild 
(nearly all less than 2 fold, majority less than 1.5 fold) effects on steady state 
levels of both mRNA and protein. 
 In conclusion, miRNA repression in mammalian cells is likely to involve 
translational initiation inhibition followed by mRNA decay. In addition, miRNA-
mediated repression is generally mild and repressive effects may not be captured 
by mRNA quantification alone. 
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1.5 Regulatory motifs and physiological roles 
 Despite the increasing complexity emerging around the regulation of 
specific miRNA production and function, the core principle of miRNA-mediated 
function is simple: miRNAs serve as guide strands to target multiple transcripts 
for repression. miRNAs bear some similarities to protein transcription factors:  
they can inhibit expression of hundreds of genes based on sequence 
determinants, and do so in combination with other miRNAs to increase 
specificity of regulation. 
 In this framework, the roles of some miRNAs are analogous to that 
ascribed to transcription factors, for example as binary switches during cellular 
differentiation. Such a classical switch interaction is exemplified by the first 
known miRNAs lin-4 and let-7, which are expressed to turn off specific target 
genes so as to alter cell fate decisions (3). Such a switch-like role for miRNAs has 
been observed during the differentiation of murine epidermal cells (81), smooth 
muscle cells (82) and neurons (83, 84). Similarly, miR-145 promotes 
differentiation of human embryonic stem cells by repressing pluripotency factors 
(85). Finally, comprehensive examinations of miRNAs and conserved targets 
show that they are usually expressed in a mutually exclusive manner (86, 87), 
suggesting that miRNA switches are common regulatory motifs throughout 
animal development.  
 In the above switch-like interactions, miRNAs are strongly induced 
during the cell fate transition and markedly repress the putative relevant targets, 
but miRNA expression alone is not generally sufficient to trigger the transition. 
In fact, premature miRNA expression often results in dysfunction of the 
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progenitor cell such as reduced proliferation (81, 84). It is therefore possible that 
miRNAs more generally improve the robustness of the cell fate transition by 
suppressing genes that are detrimental to the transition process. In agreement 
with this, miR-9a is not induced during differentiation of neuronal precursors 
but its presence reduces phenotypic variation by helping to suppress targets 
below a threshold level. (88).  
 Such failsafe interactions suggest a broader utility of miRNAs as a buffer 
against phenotypic variation in general (89).  Phenotypic variation might arise 
from intrinsic transcriptional noise. Transcription is an inherently noisy 
stochastic process (90) and phenotypically identical cells masks substantial cell-
cell expression differences (91). Increased stochastic variability in gene 
expression can be detrimental, and protein networks are organized to buffer 
against it (92). In support of this theory, miR-7 is required to maintain cell fate 
decisions in the presence of temperature fluctuations, which increases the 
stochasticity of gene expression (93).  
 These switch-like and buffer-like regulations reduce target proteins below 
a threshold, so as to trigger or sharpen a binary process. The mild influence of 
miRNA on the expression of most protein targets suggests that fine-tuning of 
cellular processes is another important regulatory motif. In this context, the 
protein targets are expressed at a defined optimal range by one or more 
miRNAs, and deviations above and below this range are both detrimental. This 
form of regulation has been observed in a number of terminally differentiated 
cell types. For example, miR-181 regulates T-cell sensitivity, while miR-223 
regulates neutrophil sensitivity. In Drosophila, miR-8 tunes the levels of atrophin 
to regulate neurodegeneration (94).  
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 Recently, studies have begun to reconcile these different modes of 
interactions found in mammalian cells. When considering target changes in large 
cell populations, as is the case in many murine experiments, theoretical analysis 
suggests that buffering of small stochastic transcriptional noise can be 
accompanied by mild aggregate repression comparable to that associated with 
fine-tuning effects (95). This indicates that tuning interactions found in 
population based measurements does not exclude the possibility of buffering 
effects in single cells.  
 This notion has found experimental support recently. Using single-cell 
measurements, Mukherji et al. showed that while aggregate repression is 
modest, large variations in repressive effect occur between cells. They further 
demonstrate that switch-like and fine-tuning interactions may occur for the same 
miRNA-target pair depending on the relative abundance of miRNA and mRNA 
target under a given condition (96). It is also likely that in different cell types, 
miRNAs target not just different mRNAs but regulate them in different manner, 
limiting the generalizability of specific miRNA-target interactions drawn from 
studies performed in cultured cells or in one cell type.  
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1.6 microRNAs in neurons: expression and function 
 Post-transcriptional mechanisms are important in the regulation of 
neuronal physiology and information processing. For example, proteins like 
FMRP regulate the translation of specific genes while proteins such as TSC 
control global translational output, and deficiency of either results in severe 
cognitive and neurological defects. As post-transcriptional regulators, miRNAs 
are similarly critical to the function of neurons. 
 Since the maturation of nearly all mammalian miRNAs are dependent on 
the canonical pathway outlined before, animals deficient for one or the other of 
these pathway components provided some of the first demonstrations of the 
importance of miRNAs in mammalian neuronal physiology.  
 Loss of Dicer enzyme is embryonic lethal (97), therefore conditional 
deletions of Dicer have been used to study the role of miRNAs in several brain 
regions and neuronal populations. These mutants show that miRNAs have a 
important role in neuron survival. Specific loss of Dicer in a variety of neuronal 
populations (including cerebellar Purkinje cells, forebrain principal neurons, 
midbrain dopamine neurons and retinal cells) consistently led to increased 
apoptosis and cell death (40, 98-100).  
 Other deficiencies that result in only partial miRNA depletion have been 
useful to reveal milder phenotypes. Haplo-insufficiency of the Microprocessor 
component and Drosha binding partner DGCR8 impairs biogenesis of a subset of 
miRNAs in the adult brain and resulted in behavioral and cognitive deficits 
reminiscent of human 22q11.2 microdeletions (101). Loss of Ago2 in Dopamine 
receptor 2 (Drd2) positive neurons in the striatum results in partial depletion in a 
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subset of expressed miRNAs, and reduced cocaine addiction (102). 
 More recently, several groups have focused on specific miRNAs (103) and 
I will highlight a few below. Overexpression of miR-125b induces the formation 
of long thin spines and reduced mEPSC amplitude, while reduced miR-125b 
increases the width of dendritic spines (104). miR-138 also negatively regulates 
spine size and excitatory mEPSCs (105). Both studies examined miRNA function 
in spine formation in cultured neurons.  
 Other studies have used knockdown of miRNAs in murine brain, 
allowing further characterization in their physiological context and examination 
of behavioral alterations. Overexpression of miR-137 in newborn cells in the 
adult dentate gyrus reduced dendritic complexity and spine density (106), while 
miR-134 is expressed near dendritic spines and negatively regulates spine size 
(107). Interestingly, overexpression of miR-134 in the hippocampus abrogates 
long-term potentiation in CA1 neurons, and impairs memory formation in the 
contextual fear-conditioning paradigm (108). That study represented a rare 
example in which perturbation of a single miRNA led to changes in learned 
behavior. Another significant example is that of miR-212, which is induced by 
extended cocaine self-administration in rats. Overexpression and knockdown of 
miR-212 in the striatum results in reduced and enhanced cocaine intake 
respectively (109).  
 In all the above case studies, miRNA knockdown was achieved by non-
genetic means using modified RNA such as antagomirs and locked nucleic acid 
(LNA) as well as miRNA-sponges. In contrast, far fewer genetic mutants of 
specific miRNAs have been generated. A couple of unique difficulties make 
genetic models of miRNA function challenging. Firstly, many miRNAs exist as 
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multigene families, with distinct members expressed from multiple loci but 
sharing very similar seed sequences, resulting in functional redundancy. 
Secondly, many miRNAs are expressed in tightly spaced poly-cistronic 
transcripts, making it difficult to delete one miRNA without affecting co-
expressed miRNAs at the same locus. One notable example is that of the poly-
cistronic transcript which expresses both miR-132 and miR-212. Deletion of the 
entire locus in newborn hippocampal neurons resulted in dramatically reduced 
dendritic length and spine density. The authors disentangled the relative 
contributions of the two miRNAs by demonstrating that only miR-132 is 
functionally expressed in these neurons (110).  
 Studies of changes in miRNA expression in pathological tissue from 
human patients and disease model animals hinted at the clinical relevance of 
these findings. Significant changes in miRNA levels were found in tissue samples 
from patients of neurodegenerative diseases such as Huntington's disease and 
Alzheimer's disease (111-113). Other changes have been noted in post-mortem 
tissue from sufferers of schizophrenia and schizoaffective disorder (114, 115). In 
spite of this, few specific roles have been attributed to miRNAs in the 
modulation of either neurodegenerative or psychiatric disorders.  
 The above studies nearly always ascribe miRNA-dependent phenotypes 
to single targets, often selected on the basis of predicted seed interactions and 
shown to be plausible targets using reporter constructs in culture. The 
contribution of single miRNA-target pairings to the observed effects is often not 
directly addressed and when it is, has somewhat limited explanatory power. 
Target discovery tools detailed in the previous sections have not been utilized in 
the study of neuronal miRNAs. In summary, evidence of the various roles of 
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miRNA in post-developmental neuronal function has accumulated in recent 
years but there exist significant gaps in our current understanding. 
 In the following chapters, I will present the results of our study. First, we 
demonstrate that changes in miR-128 levels in the principal projection neurons of 
the forebrain sensitively tune motor activity and seizure susceptibility. Second, 
we show that miR-128 is uniquely important in striatonigral projection neurons. 
Third, we have found that miR-128 represses a specific subset of target genes in 
this neuronal population. Lastly, we show that miR-128 regulates ERK signaling 
and suppresses electrical excitability as well as transcriptional response.  
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Chapter 2 miR-128: Expression and function in forebrain principal 
projection neurons 
 26 
2.1 Spatial enrichment of a neuronal miRNA 
 A large body of work over the last decade has examined the expression 
levels of a large and growing list of mammalian miRNAs in a nearly exhaustive 
list of organs and tissues obtained at various developmental stages and disease 
states.  
 A notable point that arises from these studies is the very high level of 
tissue and developmental stage specificity to miRNA expression. Many well-
established central nervous system (CNS)-specific miRNAs such as miR124a are 
highly expressed at the earliest stages of neuronal differentiation and are likely to 
have a most substantial role in developmental processes (116, 117). However, 
these expression studies also consistently identify a handful of well expressed 
miRNAs with specific expression in the mature CNS, suggesting an involvement 
in the processes of neuronal information processing that underlie learning and 
behavior. Among these, one specific miRNA, miR-128, exhibits an intriguing set 
of characteristics.  
 Northern blot quantification of miRNAs from a panel of human and 
mouse organs reveal a number of miRNAs that are brain specific in both species 
including miR-128, miR9, miR132, miR137, miR139 (118). Microarray 
quantification of miRNA in the developing and adult brain shows that a number 
of miRNAs including miR-128, miR132 and miR29 among others are strongly 
upregulated during development to reach peak expression levels in adult. (119). 
Expression profiles based on cloning frequency reveal that miR-128 and miR143 
are enriched in the adult cortex, striatum and hippocampus compared to the 
embryonic brain and various neuroblastoma and glioblastoma cells (120).   
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 Our own quantification of miR-128 levels using semi-quantitative RT-PCR 
shows that miR-128 is expressed in the CNS at higher levels than any other organ 
examined (Figure 3a). miR-128 expression begins just before birth and accelerates 
rapidly after birth into adulthood after which it remains at peak levels (Figure 
3b).  
 Although hundreds of bona fide miRNAs have been identified from 
mammalian tissue, a majority is expressed at very low levels and only a few 
dozen are consistently expressed at high levels in one or more tissues. 
Differences in expression levels often span a few orders of magnitude. Using 
absolute quantitation with RT-PCR and synthetic miRNA mimics, we found that 
the expression of miR-128 in the adult brain is very high (~104 per cell) (Figure 
3e), comparable to the expression of ubiquitous miRNAs such as let-7 (121). 
 miR-128 appears to be a vertebrate innovation, as it has been identified in 
the lamprey genome but has not been identified in any invertebrate genome so 
far. In most vertebrates, miR-128 is expressed from hairpins encoded at two 
distinct loci: miR-128-1 and miR-128-2, which are located in the longest introns of 
two related protein coding genes (R3Hdm1 and Arpp21 respectively). Both 
proteins share a common putative RNA-binding R3H domain.  
 Sequence divergence of the hairpins is nearly identical to sequence 
divergence of the protein coding host genes, suggesting that the association 
between miR-128 and members of the R3H domain protein family formed before 
duplication of the ancestral loci.  
 Interestingly, studies examining the distribution of miRNA expression in 
the adult and developing zebrafish CNS show that the highest expression was 
detected in adult forebrain structures including the telencephalon (122, 123). In-
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situ hybridization studies using LNA probes against mature miR-128 show that 
expression is higher in forebrain structures such as olfactory tubercle, cortex, 
striatum and the hippocampus (Figure 3c,d). The high and restricted miR-128 
expression pattern, as well as the conservation of this pattern across the 
vertebrate lineage, strongly suggests an involvement in post-developmental CNS 
function. 
 Recently developed techniques extend these expression studies by 
profiling miRNAs expressed in genetically-defined neuronal populations. One 
such study showed that, within the cortex, excitatory Calcium-calmodulin kinase 
2a (Camk2a)-positive neurons expressed much higher levels of miR-128 than 
inhibitory GAD-positive neurons, indicating a greater spatial specificity than 
previously appreciated. Among miRNAs expressed in Camk2a-positive neurons, 
miR-128 is one of the most highly expressed (124). 
 While this and other previous studies have quantified the relative 
expression of miRNAs among related cell or tissue types, it remains unclear what 
the significance of these differences in expression levels might be, especially in 
relation to the number and distribution of targets and in relation to the strength 
and kinetics of repression. One alternative to expression profiling to gauge the 
relative functional importance of miRNAs is to examine in-vivo targeting of 
messenger transcripts, for example quantifying the density of targets of a given 
miRNA among the set of all Ago-RISC bound transcripts.  
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Figure 3. Postnatal forebrain enrichment of miR-128. 
a, Expression levels of mature miR-128 were quantified by qRT-PCR from organs 
of adult mice and expressed relative to the mean levels in liver. (n=2).  
b, miR-128 and neuronal miRNA miR-124a in adult and embryonic brain (E12) 
were quantified as in a and expressed as fold increase over expression levels in 
the embryonic brain (n=3).  
c, Expression of miR-128 in adult brain shown by in-situ hybridization on sagittal 
brain slice using antisense LNA-probe to mature miR-128.  
d, miR-128 levels in selected brain regions were quantified by qRT-PCR and 
expression levels are expressed relative to mean hippocampus expression. (n=3).  
e, Absolute quantification of miR-128. Titration standard (left) showing qRT-PCR 
cycle number for varying concentrations of synthetic mature miR-128 (left). 
Estimated per-cell copy number of miR-128 in adult striatal samples (n=16) 
(right) assuming an average of 15 pg total RNA per cell. Bold line indicates 
sample mean.  
Error bars show s.e.m. 
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Figure 3. Postnatal forebrain enrichment of miR-128.
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2.2 CLIP-Seq isolation of miRNA targets in projection neurons 
 To do this we made use of data generated by visiting student Morten 
Venoe here in the lab, who identified Argonaute binding sites on expressed 
transcripts in mature projection neurons. Briefly, we generated mice that permit 
conditional Cre-dependent expression of Argonaute2 (Ago2) protein tagged with 
a Flag epitope. Transgenic mice were crossed to mice expressing the Cre 
recombinase in Camk2a-positive neurons, generating doubly transgenic animals 
in which tagged Ago2 was expressed only postnatally in projection neurons of 
the cortex, hippocampus and striatum. Ago-bound and protected RNA 
sequences were isolated using an adapted protocol similar to one published 
previously (63): starting with dissected and homogenized half forebrain samples, 
RNA transcripts were UV-crosslinked to bound protein, unbound RNA was 
digested, and tagged Ago2 protein was immuno-precipitated using antibody 
against the Flag epitope. Adaptors were ligated to both ends of the RNA 
fragments in the immuno-precipitated fraction and RNA was de-crosslinked 
from protein by protease digestion. RNA fragments were then sequenced, 
processed for quality and trimming of adapter sequences, and aligned to the 
mouse genome (mm9) (Figure 4a). 
 The dataset of sequenced fragments forms clusters of overlapping RNA 
fragment reads that correspond to putative sites of miRNA-RISC binding (Figure 
4b). As the miRNAs that mediate the binding to each cluster cannot be 
definitively determined from the data, we made use of the fact that most miRNA 
targeting is determined by the minimal seed site hexamer (125). The candidate 
miRNA(s) potentially mediating Ago-RISC targeting to each cluster can be 
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Figure 4. Ago2 associated mRNAs in Camk2a-positive projection neurons. 
a, CLIP-seq bound sites are enriched in 3'UTRs of mRNAs. The distribution of 
the mouse (mm9) genome (left) and CLIP-seq read clusters (right). 
b, Example CLIP-seq cluster of sequenced reads on the 3'UTR of Slc39a13 gene, 
with a miR-128 6mer target site indicated below. 
c, Scatter plot showing statistical enrichment of all 4096 possible 6mers in CLIP-
seq clusters located within Refseq annotated 3’UTRs. x-axis shows z-score which 
is the number of standard deviations the observed frequency of a hexamer 
exceeds the normalized frequency of occurrences in the corresponding RefSeq 
region. y-axis shows -log(p-value) from chi-squared test. Hexamers enriched 
above Refseq background are shown as grey dots; 6mer complementary to the 
miR-128 seed is highlighted in red. Green line represents Bonferroni-corrected 
critical p-value: 0.05/(46)= 1.22x10-5. 
d, Distribution of cluster read-count among miR-128 CLIP-seq targets, defined as 
genes with miR-128 target 6mer-containing CLIP-seq clusters within their 
3'UTRs. Genes are ranked by total associated read-counts from left to right and 
read-counts for each gene are shown. 
e-f, Genes with above-average CLIP-seq cluster read-counts are associated with 
neurological disorders and neurotransmission. Functional annotations 
significantly associated with miR-128 CLIP-seq targets shown in d were obtained 
by IPA Ingenuity analysis and the median and average per-gene read counts for 
each annotation are shown in scatter plot (e).  Annotations associated with high 
read counts are highlighted, all other annotations are shown in grey circles.  
Specific highlighted annotations are shown with associated gene count, p-value, 
and median and average read-counts (f).  
Figures a-c courtesy of Morten Venoe. 
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Figure 4. Ago2-associated mRNAs in Camk2a-positive projection neurons 
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identified by the presence of hexamers complementary to the miRNA seed site 
within each cluster. Consequently, the potential in-vivo targets of each miRNA 
can be determined. 
 Analysis of the combined sequence space given by all read clusters was 
performed to determine if any particular hexamer sequence was enriched in 
Ago-bound sites over the corresponding genomic region (3'UTR) as a whole. The  
hexamer corresponding to the binding complement of the miR-128 seed was the 
most enriched hexamer sequence (Figure 4c). Targets of miR-128 are therefore 
among the most over-represented miRNA targets among all neuronal Ago-
bound transcripts.  
 The targets of miR-128 include 707 unique target genes (Figure 4d), whose 
roles encompass a substantial range of neuronal processes based on literature-
curated functional annotation-IPA (Ingenuity® Systems, www.ingenuity.com). 
To parse the relative importance of these functional annotations, we examined 
the read count density of each target.  Targets with higher read count density are 
deemed to be more likely to be functionally relevant.  The median read count of 
each cluster is 26, with a surprisingly wide range of up to hundreds of reads. 
Since each functional annotation is based on a defined subset of target genes, 
each of which can be assigned a read count, we calculated the average and mean 
read counts associated with each annotation. We have plotted the average and 
median gene read counts on a scatter plot, with each point representing a single 
annotation (Figure 4e,f). 
 This analysis of miR-128 targets suggests that miR-128 is likely to have 
important roles in neuronal plasticity and in disorders such as seizures and 
motor disorders. We address this hypothesis in the following chapter.
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2.3 miR-128 expression in projection neurons suppresses spontaneous seizures 
and locomotor activity  
 To assess the effect of miR-128 levels on neuronal physiology and the cell 
specific role of miR-128, we generated mouse models that permit the conditional 
deletion of the miR-128 loci as well as the conditional overexpression of miR-128.  
 For the deletion models, we generated mice carrying floxed alleles of each 
of the two miR-128 loci (Figure 5). These alleles contain loxP sequences that flank 
the miRNA hairpins, enclosing  the 1-kilobase region centered on the 2 hairpins. 
The presence of loxP sequences permits excision of intervening sequences by Cre 
recombinases which are expressed in a cell-type specific manner, thus allowing 
for the genetic deletion of miR-128 hairpins in restricted cell populations. The 
presence of modified alleles in our mice models was confirmed by Southern blot 
analysis against genomic DNA with an external probe, as well as by PCR 
amplification and sequencing of modified regions. Regular genotyping was 
performed with PCR reactions that permit rapid identification of wild type, 
floxed and null (excised) alleles. 
 Crossing targeted floxed mice to transgenic mice ubiquitously expressing 
Cre-recombinase generated germline deletions of both loci. Examination of null 
mutants revealed a heavy bias in loci contribution to mature miR-128 levels in 
the brain. Deletion of miR-128-2 reduced brain miR-128 levels by 80% while 
deletion of miR-128-1 produced reductions of only 20% (Figure 6a-c). In addition, 
the heterozygous condition resulted in approximately half the depletion 
compared the null condition. These data suggest that no significant 
transcriptional/processing compensation occurs in the absence of one miR-128 
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Figure 5. Deletion targeting strategy. 
 
Figure 5. Deletion targeting strategy. 
Targeting strategy for miR-128-1 (left) and miR-128-2 (right) loci. 1 kb region 
containing the miRNA hairpin was flanked with loxP sequences to generate miR-
128-1fl/fl and miR-128-2fl/fl  mice. miRNA hairpin (blue rectangles); exons (grey 
rectangles); loxP sites (black triangles); DTA - diphtheria toxin gene; TK - 
thymidine kinase gene; LAH/SAH - long/short arms of homology. Neomycin 
resistance gene flanked by frt sequences (black circles) was removed from 
targeted locus in vivo using Flp recombinase transgenic mice. Modified alleles 
were identified by probing EcoRI or SacI digested genomic DNA with DNA 
probes 1 and 2, respectively (black rectangles).
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Figure 6. miR-128 levels are reduced by miR-128-1 and miR-128-2 deletion. 
 
Figure 6. miR-128 levels are reduced by miR-128-1 and miR-128-2 deletions. 
a, Mating scheme for generation of germline and postnatal deletions.  
b, miR-128-2 is the dominant locus. miR-128 levels in the brains of miR-128-1-/- 
and miR-128-2 mice were assayed by qRT-PCR and expressed relative to mean 
wildtype levels. n=3-5.  
c, Germline and neuronal deletion of miR-128-2 result in similar reductions of 
miR-128 levels, n=4-5. 
d, , Levels of other miRNAs were unaffected in the absence of miR-128-2. miRNA 
levels from Camk2a mutants and controls (n=2) were quantified by Taqman Low 
Density qRT-PCR arrays. Scatter plot shows normalized expression levels given 
by delta Ct (raw cycle count - global average cycle count) in mutant and control 
samples. Dotted lines indicate 2 fold increase or decrease relative to control. Red 
dot corresponds to mature miR128. 
Error bars show s.e.m.* p<0.05; ** p<0.01; *** p<0.001, Welch's t-test.
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allele. Due to the dominant contribution of miR-128-2, all deletion mutants 
mentioned subsequently in this thesis will refer to this locus alone unless 
otherwise stated. 
 For the conditional overexpression models, we used homologous 
recombination to insert a transgene segment into an intron of the ROSA26 gene, 
which is ubiquitously expressed (Figure 7a). The transgene consists of a strong 
CAG promoter (a combination of cytomegalovirus early enhancer element and 
chicken beta-actin promoter), a transcriptional STOP cassette flanked by loxP 
sequences, and a 1 kilobase genomic sequence that includes the miR-128-2 
hairpin. In the absence of Cre recombinase expression, the STOP cassette 
terminates transcription upstream of the miR-128-2 hairpin. In the presence of 
Cre recombinase, the STOP cassette is excised and strong transcription of miR-
128-2 hairpin occurs. Gene targeting was confirmed by Southern blot analysis 
using an external probe and PCR amplification and sequencing. Modified locus 
was followed by PCR-based genotyping. Cre-dependent expression of miR-128 
was confirmed in both embryonic stem cells and in the adult brain. The level of 
overexpression in the brain was mild, possibly due to the high endogenous levels 
already present (Figure 7b,c). 
 Examination of these miR-128 mutants demonstrates that miR-128 
regulates seizure susceptibility and motor functions. While miR-128-2 null 
mutants were fertile and viable, they had severely restricted lifespans, with a 
median of about 55 days (Figure 8a). We suspected that mutants had succumbed 
to seizures as home cage deaths were sudden and spontaneous and exhibited 
postural signs of seizures such as extended posture. Continuous video recording 
of mutants in the home cage captured intermittent bouts of severe spontaneous 
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Figure 7. Targeting strategy for transgenic expression. 
 
Figure 7. Targeting strategy of transgenic expression. 
a, Left: Targeting strategy for conditional overexpression of miR-128 using 
knock-in transgenic strategy at the ROSA26 locus. A 1-kb region that includes the 
miR-128-2 hairpin (red rectangle) was cloned downstream of a strong CAG 
promoter and a floxed-STOP-Neomycin cassette. Modified allele was identified 
by Southern blot (top right), or PCR genotyping (bottom right). 
b, Mating scheme for postnatal neuron-specific overexpression of miR-128. 
c, miR-128 levels in striata of double transgenic (Camk2a-cre; ROSAmiR-128/miR-128), 
single transgenic (Camk2a-cre; ROSA+/miR-128), or wild type mice (n=3 each) were 
measured by qRT-PCR. Error bars show s.e.m. * p<0.05 Welch's t-test
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tonic-clonic seizures (Figure 9a). Strong seizure episodes preceded deaths of 
recorded mutants. Consequently, we were able to rescue survival by continuous 
administration of the anti-convulsant valproate, demonstrating that fatalities 
resulted from a severe epileptic condition (Figure 9b).  
 Furthermore, miR-128-2 null animals were significantly more hyperactive 
than wild type animals in the open-field chamber (Figure 8b,c). For open-field 
chamber quantification, horizontal distance traveled was measured over an hour 
for animals exposed to a novel chamber. Mutants treated with valproate also 
remained hyperactive, suggesting that hyperactivity was not dependent on the 
development of prior seizures (data not shown). In agreement with the low 
expression at the miR-128-1 locus, deletion of this locus produced no significant 
hyperactivity and no increases in mortality (data not shown). 
 Using cell-type specific isolation and quantification of Ago-associated 
miRNAs, a previous study had shown that miR-128 was highly enriched in 
Camk-positive excitatory neurons compared to GAD-positive inhibitory neurons 
(124).  Given that result, in combination with our observation that miRNA targets 
in Camk2a neurons were highly enriched for miR-128 targets, we hypothesized 
that deletion of miR-128 in this neuronal population alone might recapitulate 
most if not all of the observed mutant phenotypes.  
 Projection neuron-specific deletion of miR-128-2 was generated by 
crossing floxed mice with mice expressing Cre recombinase in Camk2a neurons 
(Figure 6a). Cre expression was present in principal neurons of the cortex and 
hippocampus as well as medium spiny neurons of the striatum. Cre expression 
starts in the first week after birth and reaches maximum at P15, allowing 
temporal restriction to to post-migratory mature neurons (126).
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Figure 8. Germline and neuron-specific deletion of miR-128-2. 
 
Figure 8. Germline and neuron-specific deletion of miR-128-2. 
a and d, Premature mortality. Kaplan-Meier plot showing percentage of 
surviving animals as a function of days after birth in a, germline deletions: miR-
128-2-/- (n=20, median 55 days), miR-128-2+/- (n=49), miR-128-2+/+ (n=46). 
p<0.0001, log-rank test, and in d, postnatal neuron deletions: Camk2a-cre; miR-
128-2fl/fl (n=25, median 56 days), Camk2a-cre; miR-128-2wt/fl (n=26), wild type 
controls (n=68). p<0.0001, log-rank test. 
b, c, e and f, Increased motor activity. b and e, Total horizontal distance travelled 
in open field chamber over 60 minutes. c and f, Total vertical episodes (rearing) 
in open field chamber over 60 minutes. b and c, miR-128-2-/- (n=12), miR-128-2+/- 
(n=14) and wild-type littermates (n=23). e and f, Camk2a-cre; miR-128-2fl/fl (n=8), 
Camk2a-cre; miR-128-2wt/fl (n=21) and wild-type littermates (n=41).  
Error bars show s.e.m. 
* p<0.05; ** p<0.01; *** p<0.001, one-way ANOVA followed by Tukey's post test.
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Figure 9. Premature mortality is caused by an epileptic condition. 
 
Figure 9. Premature is caused by an epileptic condition. 
a, Depletion of miR-128-2 results in severe, spontaneous seizures. Daily 
frequency of tonic-clonic seizures of a miR-128-2-/- (average 0.45 seizures per day) 
and two Camk2a-cre; miR-128-2fl/fl mutants (average 0.77 and 0.54 seizures per 
day) during the 22-day period preceding a recorded fatal seizure.  
b, Mortality is rescued by administration of anti-convulsant valproate. Kaplan-
Meier plot showing miR-128-2-/- mice (n=11) treated with sodium valproate from 
weaning to 90 days of age (red line), compared to untreated mutants (black) 
Percentage survival of miR-128-2-/- mutants at age 90 days: valproate 
treated=90% ; untreated=8%. p<0.001 log-rank test.
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 Projection neuron specific deletion of miR-128-2 (Camk2a-cre; miR-128-2fl/fl) 
produced a reduction of mature miR-128 levels in the adult brain identical to that 
observed in miR-128-2 null mutants (Figure 6c,d). This suggests that previous 
estimates of Camk2a-neuron miR-128 enrichment are likely to be an 
underestimate. This is perhaps unsurprising given the likelihood of cross-
contamination during the isolation process. Importantly, Camk2a-cre; miR-128-
2fl/fl mutants had identical reductions in lifespan and increases in basal locomotor 
activity as null mutants (Figure 8d-f). These results suggest two important 
conclusions: (i) the biological function of miR-128 relates to function of post-
developmental mature neurons and (ii) miR-128 is uniquely important to 
processes that occur in this neuronal subset. 
 To rule out the possibility that the effects demonstrated by the genetic 
deletion of miR-128-2 might be caused by unintended perturbations of the host 
gene (Arpp21) or neighboring genes, we crossed Camk2a-cre; miR-128-2fl/fl 
mutants to transgenic animals that overexpress miR-128 so that miR-128-2 
deletion and expression from the ROSA locus both occurred in Camk2a-neurons. 
This genetic rescue experiment showed that miR-128 alone was sufficient to 
normalize survival rates and locomotor activity (Figure 10). 
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 The relation between the concentration of miRNA in a cell and the 
resultant effects on physiology are thought to depend on the expression profile 
of its targets. In its role as a buffer against transcriptional noise, miRNAs 
suppresses the translation of rare aberrant transcripts, in which case the cell 
might be insensitive to relatively large changes in miRNA concentration above a 
certain concentration at which all relevant target transcripts are bound. In its role 
as a fine-tuner of transcript expression, moderate changes in miRNA 
concentration might lead to similar changes in target transcript availability and 
expression, and in turn that of cellular properties. 
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Figure 10. Transgenic miR-128 expression rescues epilepsy and hyperactivity 
 
Figure 10. Transgenic miR-128 expression rescues epilepsy and hyperactivity . 
a, Expression of miR-128 from transgenic allele rescues epileptic mortality in 
Camk2a deletion mutants. Kaplan-Meier survival plot for homozygous Camk2a 
deletion mutants carrying no transgenic alleles (black, n=9, median lifespan 71 
days), or one transgenic allele (light blue, n=11, median lifespan 129 days) or two 
transgenic alleles  (dark blue, n=4, median >200 days).  
* p<0.05; *** p<0.001, log rank tests. 
b, Expression of miR-128 from conditional transgenic allele normalizes 
hyperlocomotion in Camk2a-cre; miR-128-2wt/fl heterozygous mutants. Total 
horizontal distance traveled over 60 minutes in an open-field chamber by 
heterozygous deletion mutants carrying either no transgenic allele (black, n=12), 
or one transgenic allele (blue, n=15) and wild type controls (white, n=25).  
Error bars show s.e.m. *** p<0.001, one-way ANOVA followed by Tukey's post 
test. 
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 Basal locomotor activity was strongly dependent on the dosage of miR-
128. Heterozygous and homozygous deletion of miR-128-2 resulted in increasing 
levels of hyperactivity in the open field. Conversely, heterozygous and 
homozygous transgenic over-expression of miR-128-2 resulted in increasing 
levels of hypo-activity compared to wild type controls (Figure 11b,c).   
 To further determine the dosage dependence of seizure susceptibility, we 
examined the survival of mice with neuronal deletion of combinations of miR-
128-1 and miR-128-2. Different combinations of loci deletions correspond to 
different levels of approximate miR-128 availability. The survival statistics 
clearly show that decreasing levels of miR-128 are correlated with increased 
mortality rates (Figure 12). 
 Finally, increased miR-128 endogenous levels suppressed the progression 
of seizures induced by chemical convulsants. Seizures developed upon 
imbalances in the ratio of excitatory to inhibitory tone. Increased excitatory tone 
can be achieved using agonists of glutamatergic receptors e.g. kainic acid. 
Correspondingly, suppression of inhibition can be achieved using GABA 
receptor antagonists e.g. picrotoxin. The proportion of miR-128 overexpressing 
mice that develop tonic-clonic seizures upon systemic administration of either 
kainic acid or picrotoxin was lower than that of controls (Figure 11a). In 
summary, loss and gain of miR-128 in Camk2a projection neurons of the adult 
forebrain increases and suppresses seizure susceptibility and motor activity 
respectively.
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Figure 11. Transgenic expression suppresses seizures and locomotion. 
 
Figure 11. Transgenic expression suppresses seizures and locomotion. 
a, Expression of miR-128 from transgenic allele suppresses chemical induction of 
tonic-clonic seizures. Percentage of mice exhibiting tonic-clonic seizures upon 
systemic injection of kainic acid or picrotoxin (n=12 per group). p-values 
calculated by Fisher’s exact test. 
b and c, Reduced motor activity upon miR-128 overexpression. b, Total 
horizontal distance traveled and c, total rearing activity in an open-field over 60 
minutes by double transgenic (black, n=21), single transgenic (gray, n=21) and 
control mice (white, n=33).  
Error bars show s.e.m. * p<0.05; ** p<0.01; *** p<0.001, one-way ANOVA 
followed by Tukey's post test.
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Figure 12. Epileptic mortality is miR-128 dosage dependent. 
 
Figure 12. Epileptic mortality is miR-128 dosage dependent. 
a, Mating scheme for generation of postnatal neuron-specific double knock-out 
of miR-128-1 and miR-128-2.  
b, Kaplan-Meier plot, percentage of surviving animals as function of days after 
birth is shown for listed mutants carrying combinations of miR-128-1 and miR-
128-2 alleles (sample number, median lifespan): Camk2a-cre; miR-128-1wt/wt; miR-
128-2wt/fl (n=26, >360 days), Camk2a-cre; miR-128-1wt/fl; miR-128-2wt/fl (n=16, 116 
days), Camk2a-cre; miR-128-1wt/wt; miR-128-2fl/fl (n=25, 56 days), Camk2a-cre; miR-
128-1wt/fl; miR-128-2fl/fl (n=11, 38 days). All pairwise log-rank test p<0.005.  
c, Line graphs summarize percentage animals surviving at 30, 40 or 50 days after 
birth for each genotype. Approximate miR-128 levels for each genotype are 
indicated.
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2.4 miR-128 expression in the striatum suppresses hyperlocomotion 
 Distance travelled during ambulatory activity is one example of a broad 
set of normal motor activities, and serves as a reliable and consistent measure of 
motor output as a whole. In the last few decades, large strides have been made 
toward understanding the distinct neuronal subsets and networks that control 
motor coordination, action selection or the magnitude of motor outputs. Some of 
these studies have been undertaken to try to understand the range of motor 
dysfunctions that afflict human patients such as Huntington’s disease or 
Parkinson’s disease.  
 The striatum is the major input structure of the basal ganglia system and 
has an important role in the control of motor output. Loss of dopaminergic tone 
within this structure is the primary cause of akinesia in sufferers of Parkinson’s 
disease.  
 To examine the relative contributions of striatal expression of miR-128 to 
the regulation of basal activity, we generated mice with region-specific deletions 
of miR-128-2. Adeno-associated virus expressing Cre-recombinase was injected 
into the striatum of miR-128-2 floxed or wild type mice. Peak expression of Cre 
recombinase occurs at around 20 days after injection. This experiment 
demonstrates that miR-128-2 deletion in the striatum was sufficient to produce 
increased baseline activity (Figure 13). 
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Figure 13. Striatal deletion is sufficient to induce hyperactivity. 
 
Figure 13. Striatal deletion is sufficient to induce hyperactivity. 
a, Schematic of striatal deletion of miR-128-2 by bilateral stereotactic injection of 
adeno-associated virus expressing Cre-recombinase (AAV-cre) into striatum of 
either miR-128-2fl/fl or wild-type mice (left). miR-128 levels in striatum of miR-128-
2fl/fl mice injected with either AAV-Cre or vehicle were quantified by qRT-PCR 
(n=3). * p<0.05, Welch's t-test. 
b-c, Striatal deletion of miR128-2 was sufficient to induce basal hyperlocomotion. 
b, Horizontal distance travelled in an open-field chamber in 10 minute intervals. 
miR128-2fl/fl (n=14) or controls (n=8) stereotactically injected with AAV-Cre.          
* p<0.05, 2-way repeated-measures analysis of variance (genotype).  
c, Total horizontal distance traveled in an open-field chamber over 60 minutes.  
* p<0.05, Welch's t-test.  All error bars indicate S.E.M.
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2.5 Summary 
 Our work confirms the post-developmental restriction and forebrain 
enrichment of miR-128. Our data also complements previous finding that miR-
128 is enriched in Camk2a-positive projection neurons by showing a strong 
enrichment of miR-128 targets among the pool of Ago2 bound transcripts in 
Camk2a-positive neurons of the adult forebrain. This CLIP-seq dataset allows us 
to narrow down the list of possible physiological targets of miR-128 and these 
targets suggest a role for miR-128 in the modulation of seizure and locomotion. 
We addressed this hypothesis by deleting miR-128 both ubiquitously and 
specifically in Camk2a-positive forebrain projection neurons. Depletion of miR-
128 in either case produced nearly identical, dose-dependent increases in 
epileptic mortality and basal locomotor activity. These phenotypes are consistent 
with a sensitive regulation of neuronal excitability by miR-128 in projection 
neurons across the forebrain. In addition we show that miR-128 loss in the 
striatum was sufficient to induce hyperactivity. In the next chapter we examine 
miR-128 function in the striatum in detail. 
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Chapter 3: miR-128 in medium spiny neurons of the striatum 
 53 
3.1 D1-MSNs and D2-MSNs: distinct projection neurons in the striatum 
 Camk2a-positive neurons in the striatum include two similarly sized 
populations of DARPP-32-positive projection neurons called medium spiny 
neurons (MSNs), which together account for over 90% of neurons in this 
structure. Morphologically identical and anatomically intermingled, these 
neurons also receive similar inputs from extra-striatal regions including 
dopaminergic input from the midbrain and glutamatergic input from the 
cerebral cortex and thalamus. However, these two populations project to 
completely distinct output structures of the basal ganglia and participate in two 
largely parallel circuits reviewed in  (127). Furthermore, these two populations 
are further differentiated by the unique expression of key proteins. Striatonigral 
projecting MSNs (D1-MSNs) preferentially express Dopamine type 1 receptors 
(Drd1), substance P and dynorphin. Striatopallidal projecting MSNs (D2-MSNs) 
preferentially express Dopamine type 2 receptors (Drd2), Adenosine type 2 
receptors (A2A) and enkephalin.  
 D1 and D2- MSNs exhibit a wide array of functional differences. They 
display distinct dendritic excitability (128), engage distinct signaling outcomes in 
response to dopamine (129, 130), employ distinct dopamine-dependent plasticity 
mechanisms (131), and mediate distinct behavioral and learning outcomes upon 
pharmacological and optogenetic stimulation (132-134). Furthermore, recent 
expression studies identified hundreds of genes differentially expressed in the 
two subtypes, expanding our understanding of known differences in signal 
transduction and integration and revealing novel ones (135).  
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 D1- and D2-MSNs of the striatum constitute a unique and fascinating 
system to study divergent signaling architectures in similar neuronal 
populations. Little is known about miRNA expression and function in MSNs, but 
miR-128 is highly expressed in the striatum and we have shown that striatal 
depletion alone can induce locomotor hyperactivity reminiscent of MSN 
hyperstimulation. Furthermore, differences in signaling responses D1- and D2-
MSNs suggest different requirements of miR-128 activity. This is the hypothesis 
we address in this chapter. 
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3.2 Relative miR-128 expression in MSN populations 
 We first determined whether miR-128 is differentially expressed between 
these two MSN populations. To this end, we generated mice expressing epitope 
tagged-Ago2 in either D1 or D2 MSNs by breeding mice carrying the conditional 
tagged-Ago2 allele with the respective Cre-driver lines. Tagged Ago2 was 
immunoprecipitated from adult striatum tissue and total bound RNA was 
isolated and the levels of most major murine miRNA families were quantified 
using qRT-PCR on low-density arrays (Figure 14a). To correct for background 
contamination by non-specific pull-down of miRNA, mice not expressing Cre 
were used as controls, and processed in parallel. 
 Among all tested miRNAs, 184 were recovered at levels above non-
specific background. To compare expression levels between the two cell types, it 
was necessary to normalize for the total isolated miRNA content of each 
population. This was done in two ways: (1) using cycle count for miR-124, a 
highly expressed neuronal miRNA induced early in neuronal differentiation and 
(2) using the global mean cycle count for all miRNAs expressed above 
background. Only miRNAs showing significant differences using both methods 
were considered to be differentially expressed between D1 and D2-MSNs (Figure 
14b). The analysis shows that 21 miRNAs were more highly expressed in D1 
MSNs, including miR-128, and that 12 miRNAs were more highly expressed in 
D2 MSNs. Real time PCR quantification was repeated and we confirmed that 
miR-128 was expressed about two fold higher in D1 MSNs than D2 MSNs, 
suggesting D1-MSNs make a greater contribution to the dysfunctions of miR-128 
mutants (Figure 14c).  
 56 
Figure 14. Differential expression of miR-128 in D1 and D2 MSNs. 
  
Figure 14. Differential expression of miR-128 in D1 and D2-MSNs. 
a, Schematic summarizes generation of mice expressing flag-tagged Ago2 in 
either D1- (green) or D2- (red) MSNs and cell-type specific isolation of Ago2-
associated miRNAs. 
b, Left: miRNAs were quantified by qRT-PCR and normalized using cycle count 
(Ct) of either the population median or miR-124a. Only the 33 miRNAs with 
significant (p<0.05) differential expression in both cases were considered. Right: 
Relative miRNA expression of selected miRNAs.  
c, Left: Mating scheme to delete miR-128-2 in D1 or D2-MSNs in the striatum. 
Right: miR-128 levels in adult striatum upon deletion in D1- or D2- MSNs.  
All error bars indicate S.E.M. *** p<0.001 ** p<0.01, * p<0.05, Welch's t-test.  
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3.3 miR-128 has a unique role in D1-MSNs 
 To test whether D1-MSNs provide a greater contribution to the observed 
hyperlocomotion and seizures, we generated mice with deletion of miR-128-2 in 
either D1- or D2-MSNs (hereafter Drd1a-cre; miR-128-2fl/fl and A2a-cre; miR-128-
2fl/fl respectively). To help quantify the non-striatal contribution to hyperactivity, 
we also generated mutants in which miR-128-2 was deleted in all neuronal 
populations of the hippocampus and cortex (Emx-cre; miR-128-2fl/fl). These 
subtype-specific deletions exhibited interesting differences of phenotype. 
 Reductions in pan-striatal miR-128 levels upon deletion in D1-MSNs were 
greater than that upon deletion in D2-MSNs, supporting our previous 
observation that miR-128 was comparatively enriched in D1-MSNs (Figure 14c). 
In the open-field assay, Drd1a-cre; miR-128-2fl/fl mutants displayed a strong 
hyperactivity compared to controls similar to that observed with Camk2a-cre; 
miR-128-2fl/fl mutants (Figure 15a-c). Like Camk2a-cre; miR-128-2fl/fl mutants, the 
increased locomotor activity of Drd1a-cre; miR-128-2fl/fl mutants was not 
accompanied by increased thigmotaxis (the tendency of mice to conduct most of 
their exploratory behavior at the periphery of the chamber due to the presence of 
tactile responses to chamber walls). Other measures of behavioral anxiety using 
elevated plus maze and light-dark chamber also confirmed that hyperlocomotion 
was not accompanied by increased anxiety (data not shown). In contrast, A2a-cre; 
miR-128-2fl/fl mutants showed no difference in locomotor activity compared to 
wild-type littermates (Figure 15d-f). 
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Figure 15. miR-128 deletion in D1 but not D2 MSNs results in hyperactivity. 
Figure 15. miR-128 deletion in D1 but not D2 MSNs results in hyperactivity. 
Open field activity of Drd1a-cre; miR-128-2fl/fl mutants (a-c), A2a-cre; miR-128-2fl/fl 
mutants (d-f), and Emx-cre; miR-128-2fl/fl mutants (g-i). 
a, d, g, Horizontal activity in 10 min intervals. b, e, h, Total horizontal activity 
over 60 mins. c, f, i, Total rearing activity over 60 mins.  
All error bars indicate S.E.M. *** p<0.001 ** p<0.01, * p<0.05, Welch's t-test. 
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 Emx-cre; miR-128-2fl/fl mutants displayed a milder locomotor phenotype 
that was also qualitatively different from that of Drd1a-cre; miR-128-2fl/fl mutants 
(Figure 15g-i). These mutants showed the greatest activity difference occurs in 
the initial period of exposure to the open field chamber and this activity 
difference progressively narrowed over time. Two-factor (time and genotype) 
analysis of variance (ANOVA) showed a clear dependence on both and a 
significant interaction between the two factors. In contrast, Drd1a-cre; miR-128-
2fl/fl mutants showed identical activity increase over controls throughout the 60 
minutes in the open field chamber. Two-way ANOVA showed a lack of 
dependence on time interval and no interaction between time interval and 
genotype. This suggests that while miR-128 deletion in D1-MSNs produces 
constant elevated activity, deletion in the cortex and hippocampus results in 
higher novelty-induced locomotion, which diminishes over time. The severe 
phenotype seen in Camk2a-cre; miR-128-2fl/fl mutants is likely to result from a 
combination of these two aspects. 
 Finally, Drd1a-cre; miR-128-2fl/fl mutants displayed spontaneous home 
cage seizures resulting in increased mortality although not as severe as that 
observed in Camk2a-cre; miR-128-2fl/fl mutants, with a median lifespan of 142 days 
(Figure 16a) In contrast, A2a-cre; miR-128-2fl/fl mutants showed no increase in 
mortality over littermates and all mutants survived over a year (Figure 16b).  
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 The rate of epileptic mortality was even greater in Emx-cre; miR-128-2fl/fl 
mutants, with a lower median lifespan of 105 days, consistent with a known role 
of the hippocampus in promoting seizure generalizations (Figure 16c). 
Interestingly, using the inverse of the median lifespan to approximate the rate of 
death of each mutant line (rate = 1/(median lifespan)), a simple addition of the 
death rates of Emx-cre; miR-128-2fl/fl and Drd1a-cre; miR-128-2fl/fl mutants very 
closely approximates the death rate of Camk2a-cre; miR-128-2fl/fl mutants. 
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Figure 16. miR-128 deletion in D1 but not D2 MSNs results in fatal epilepsy. 
 
Figure 16. miR-128 deletion in D1 but not D2 MSNs results in fatal epilepsy. 
Kaplan-Meier survival plots for:  a, Drd1a-cre; miR-128-2fl/fl mutants (green, n=16) 
and controls (grey, n=39); b, A2a-cre; miR-128-2fl/fl mutants (red, n=8) and 
controls (grey, n=8) and c, Emx-cre; miR-128-2fl/fl mutants (brown, n=19) and 
controls (grey, n=54). a, c, p<0.001 log rank tests. All A2a-cre; miR-128-2fl/fl 
mutants survived for a year until they were sacrificed.
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3.4 Summary 
 Behavioral changes resulting from deletion of miR-128 in D1-MSNs but 
not D2-MSNs was sufficient to recapitulate the phenotypes observed in Camk2a-
cre; miR-128-2fl/fl mutants, suggesting a unique role of miR-128 in regulating the 
properties of D1-MSNs. The cortical-hippocampal contribution to seizure 
susceptibility is larger but we show that loss of miR-128 in D1-MSNs is necessary 
and sufficient for a novelty-independent baseline increase in motor activity and 
fatal epilepsy.  
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Chapter 4: miR-128 targets and MAPK pathway 
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4.1 Ribosomal profiling in D1-MSNs reveals regulated targets 
 The primary effect of miRNA expression is the translational suppression 
and/or degradation of specific target mRNA transcripts. Most, if not all, of the 
biological consequences of miRNA expression stems from this repression of 
target transcripts. To understand how miR-128 depletion results in the 
behavioral and cellular dysfunction demonstrated so far, we need to identify 
physiological targets of miR-128. 
 We have shown that D1-MSNs contain most of the striatum-expressed 
miR-128 and that D1 specific deletion of miR-128 results in hyperactivity and 
seizure. To determine target genes dysregulated in D1-MSNs in the absence of 
miR-128, we made use of a ribosomal profiling strategy-TRAP (135) that allows 
the comprehensive quantification of mRNA levels in a specific population of 
cells. By crossing our Drd1a-cre; miR-128-2fl/fl mutants with transgenic mice 
expressing tagged ribosomal subunits in D1-MSNs, we generated animals in 
which D1 neurons are miR-128 deficient and express tagged ribosomes. Briefly, 
Drd1a-cre; miR-128-2fl/fl mutants carrying tagged ribosomes in D1-MSNs were 
used for polysome immunoprecipitation and polysome-associated transcripts 
were analyzed by microarray. Control mice carrying tagged ribosomes but 
negative for Cre recombinase were used for comparison. Two independent 
experiments were performed involving 8 controls and 9 mutants. Using a non-
conservative analysis, over 2000 probes showed significantly different expression 
levels in the absence of miR-128 ( p<0.05, two-way ANOVA for genotype) 
(Figure 17a).
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 As typical expression changes of target genes in response to miRNAs are 
very small (<1.5 fold), and could involve an unknown number of primary 
targets, we chose a non-conservative significance cutoff and no minimum cutoff 
for fold change. While this means that most of the primary targets of miR-128 are 
likely to be included in this list, it would also include secondary expression 
changes and a significant number of false positives. To test if the expression 
changes detected include changes in primary target genes, we looked at 
differences in mean derepression levels of various sub-populations: 
 Firstly, genes with one or more miR-128 6-mer seed sites within their 
annotated full-length Refseq transcripts had much greater levels of derepression 
compared with genes that contained no sites. Furthermore, Ago-associated genes 
containing miR-128 seeds within isolated clusters (CLIP-seq) showed even higher 
levels of derepression (Figure 17b).  
 Secondly, among CLIP-seq positive genes, those in which miR-128 seed-
containing clusters occurred in the 3’UTR were more derepressed than those in 
which such clusters occurred in the coding region (Figure 17b). This is in line 
with some previous findings that most functional interactions between miRNA 
and its target occur in the 3’UTR (50, 51)
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Figure 17. Ribosomal expression profiling in D1-MSNs. 
a, Schematic summarizes D1-MSN specific ribosomal profiling. Mice with D1-
MSN specific deletion of miR128-2 and transgenic expression of tagged ribosomal 
subunit. Total striatum was dissected from mutant (Drd1a-cre; miR128-2fl/fl; Drd1a-
eGFP-L10a) and control (miR128-2fl/fl; Drd1a-eGFP-L10a) littermates. Polysome 
associated mRNA transcripts were isolated and profiled from 2 independent 
experiments by microarray (7-8 mice per group total). Green ribosomes: eGFP-
tagged ribosome; black ribosomes: untagged ribosomes.  
b-c, Ago-bound CLIP-seq miR-128 targets are preferentially upregulated.  
b, Mean log fold changes of all differentially expressed genes (All); genes with 
either 0 or ≥1 miR-128 6mer target site in its full annotated sequence (No 6mer 
and Refseq 6mer); and genes with 6mer-containing CLIP-seq cluster anywhere, 
in 3'UTR only, or in coding regions only (CLIP-seq 6mer, CLIP-seq 6mer 3'UTR, 
CLIP-seq 6mer ORF). Number of probes indicated in brackets. 
c, Mean log fold changes of all differentially expressed genes (All), CLIP-seq 
targets of miR-128 and that of other miRNAs. CLIP-seq targets are genes with a 
CLIP-seq cluster in the 3'UTR that contains 6mer target site(s) for a given 
miRNA. 
d, Venn diagram illustrates definition of primary target genes as miR128 CLIP-
seq targets that are differentially expressed in the absence of miR128 as shown by 
ribosomal profiling. 
 ** p<0.01, *** p<0.001, one-way ANOVA followed by Dunnett’s post test against 
group of all differentially expressed genes (All). All error bars indicate s.e.m. 
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Figure 17. Ribosomal expression profiling in D1-MSNs. 
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4.2 Primary target genes 
 Based on the above results, we restricted the list of primary targets genes 
(PTGs) to those which fulfilled the following conditions: 
1. Association with Ago2 in neurons as shown by the presence of 3’UTR CLIP-
seq cluster(s) containing at least one miR-128 6mer seed. 
2. Significant expression change in the absence of miR-128 as assayed by 
ribosomal profiling in D1-MSNs. 
 In further validation of our stringent criteria, we compared the mean de-
repression of miR-128 primary targets with that of other miRNAs using the same 
criteria (presence of miRNA seed site within Ago CLIP-seq cluster in the 3’UTR) 
and with the entire population of altered genes as a whole. Primary miR-128 
targets (and not that of other miRNAs expressed in Camk2a neurons) were 
significantly more de-repressed than the set of all altered genes (Figure 17c). This 
confirms the utility of using CLIP-seq data to isolate actual targets from the large 
population of genes with altered expression. 
 Applying the above criteria narrowed our search to 104 upregulated PTGs 
(131 probes). For comparison purposes, there are significantly fewer 
downregulated genes (40 unique genes, 47 probes) fulfilling our criteria (Figure 
17d). As miRNAs are solely thought to repress targets, the presence of this 
smaller but significant group of downregulated PTGs was taken to indicate the 
false positive rate of our analysis. For now, both groups are included in our 
analysis although we will address this issue below. 
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 To confirm that most if not all of upregulated primary targets were bona 
fide miR-128 targets, full-length 3’UTRs of 10 randomly selected targets were 
cloned downstream of a firefly luciferase gene and expressed in cultured 
Neuro2A cells. Responsiveness to exogenous miR-128 mimics co-transfected 
with the reporter plasmid could be assayed by luciferase activity. All tested 
targets showed significant repression by miR-128 mimic compared to scramble 
control mimic, while none of the negative controls showed significant responses 
(Figure 18b). 
 The level of derepression was mild, ranging for 1.2-fold to just over 2-fold 
increase in the absence of miR-128 (Figure 18a). This is in line with most previous 
studies examining the level of repression by miRNAs (58). Quantification of 
selected proteins by Western blot analysis indicated that repression of protein 
levels was only slightly higher than that observed with ribosomal profiling 
(Figure 18c). 
 The use of ribosomal profiling confers many advantages over expression 
studies using total RNA samples extracted from dissected tissue. Firstly, genetic 
targeting allows cell-specific isolation of transcripts. Therefore, expression 
changes are not diluted by the presence of transcripts from non-miR-128 
expressing cells (glia, interneurons), or cells in which miR-128 expression is 
lower and might lead to smaller repression rates (D2-MSNs). This is especially 
significant if targets are also relatively depleted within the target cell type. 
Secondly, miRNAs affect the recruitment and translation of transcripts by 
ribosomes, with mRNA degradation occurring subsequently in most but not all 
cases. Ribosomal profiling thus provides a more accurate picture of expression 
changes compared to mRNA quantification alone.  
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Figure 18. Primary target genes. 
a,  Heat map of upregulated primary target genes showing fold changes in 
ribosomal association in D1-MSNs. Genes are listed in descending order of 
average fold change over control samples. Columns show each of two 
experimental repeats. 
b, In-vitro confirmation of primary targets. Luciferase reporters carrying full 
3'UTR sequences of a subset of primary target genes were tested for responsivity 
to either scrambled control or miR-128 mimics in Neuro2A culture. Mean 
normalized luciferase activity for each reporter is expressed relative to that in the 
presence of control mimic. RCS and BDNF constructs are included as negative 
controls. All tested primary target reporters showed significant responses to 
miR128 mimics. * p<0.05; ** p<0.01; *** p<0.001, Welch's t-test. 
c, Mean protein level changes in the striatum were quantified for 3 primary 
targets D4ertd22e (left), Pea15a (middle) and Tarpp/Arpp21 (right). Bar graphs 
show mean expression levels quantified from dissected striata (n=4 each) by 
Western blot, normalized to actin loading controls and expressed relative to 
mean control expression. Representative blots for each target are shown above 
respective bar graph. * p<0.05; ** p<0.01, Welch's t-test.  
All error bars indicate S.E.M. 
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Figure 18. Primary target genes. 
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 To illustrate the advantages of this method, we made use of the Camk2a-
cre; miR-128-2fl/fl mutants described in Chapter 2. Total RNA was extracted from 
dissected striata of both mutants and their respective controls and mRNA 
expression quantified by microarray. We compared mean fold changes of the 178 
miR-128 PTGs obtained from D1-MSN ribosomal profiling experiments to those 
obtained from analyzing total striatal RNA from Camk2a-cre; miR-128-2fl/fl 
mutants. Previous work using ribosomal profiling to quantify target expression 
changes have shown that for the majority of targets, changes in ribosome 
association is accompanied by reductions in target mRNA (79). 
 The observed fold changes were significantly higher using ribosomal 
profiling as expected for the reasons listed above. In spite of this, we were able to 
detect mild derepression of nearly all the upregulated PTGs, and a very 
significant derepression of the population as a whole, suggesting that we could 
use microarray assays of total RNA to examine other properties of the PTGs. 
 We have shown earlier that miR-128 exerts a bidirectional control of both 
locomotor activity as well as seizure susceptibility. It is therefore likely that the 
primary targets of miR-128 should exhibit similar bidirectional dynamics. To test 
this, we made use of the Camk2a-cre; miR-128-2fl/fl deletion mutants and Camk2a-
cre; ROSAmiR-128/miR-128 overexpression mutants described in Chapter 2. Total RNA 
was extracted from the striata of both mutants and their respective controls and 
quantified by microarray. Up-regulated PTGs showed highly significant 
bidirectionality - up-regulated in deletion and repressed in overexpressing 
mutants (p<10^9). In contrast the 47 downregulated primary targets did not 
show bidirectionality (p>0.05), confirming our previous view that these genes 
were not primary targets (Figure 19a,b). 
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 To test if PTGs were similarly targeted in other brain regions, we dissected 
cortical, hippocampal and striatal samples from Camk2a-cre; miR-128-2fl/fl mutants 
and analyzed total RNA as above. Each PTG was marked as either up-regulated 
or down-regulated for each brain region. For example, a particular subset of the 
upregulated PTGs would be seen upregulated in the cortex, while a different 
subset might be upregulated in the hippocampus. 25 genes were not upregulated 
in any region, consistent with the lower resolution using total RNA. Of the 
remaining genes, we found a very significant overlap of upregulated genes 
across all 3 regions, suggesting a broad conservation of miR-128-target pairings 
in multiple cell types (Figure 19c,d). 
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Figure 19. Upregulated PTGs are bidirectionally regulated and shared across 
brain regions. 
Upregulated (a,c) and downregulated PTGs (b,d) are assessed for co-regulation 
across brain regions (a,b) and for bidirectionality (c,d). 
a, b, mRNA from hippocampus, striatum and cortex of Camk2a-cre; miR-128-2fl/fl 
mutants were quantified by microarray. a, Upregulated PTGs were assessed if 
they were upregulated over control samples in each region and numbers were 
represented in Venn diagram. p<0.001 for all 3-way and 2-way interactions, log-
linear analysis. b, Downregulated PTGs were assessed if they were 
downregulated over control samples in each region and similar represented. 
p>0.05 for all interactions, log-linear analysis. 
c, d, mRNA from striatum of deletion mutants (grey, Camk2a-cre; miR-128-2fl/fl ) 
and transgenic overexpression mutants (blue, Camk2a-cre; ROSAmiR-128/miR-128) were 
quantified by microarray. Mean log fold changes of upregulated PTGs (c) and 
downregulated PTGs (d) are shown. p-values calculated by paired t-test.  
All error bars indicate S.E.M.
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Figure 19. Upregulated PTGs are bidirectionally regulated and shared across brain regions.
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4.3 Convergent modulation of ERK pathway by miR-128 targets 
 The relation between miRNA targets and the apparent biological function 
of a miRNA is necessarily a complex one. Many studies have focused on the role 
of single or few targets often selected from predicted target lists based on the 
presence of miRNA seed sites. While such strategies are useful in explaining 
narrowly defined effects of miRNA perturbation, they can only partially account 
for broader phenotypic outcomes. A fuller accounting for miRNA effects might 
require examining the consequences of repression of all real target genes, but it is 
often difficult to see how large groups of genes might interact.  
 To assess if these genes converge upon common biochemical networks or 
pathways, we used literature curated analysis programs to look for enrichment 
of known pathways and networks among these genes. Ingenuity network 
analysis predicts gene networks from a given set of genes using known and 
predicted biochemical interactions, enabling diverse genes to “merge” around a 
few common interactions. Such an analysis produced a top ranked network in 
which many of the miR-128 targets we identified converge on MAP kinase-
ERK1/2 proteins (Figure 20). The MAP kinase-ERK pathway was also among the 
two pathways showing significant enrichment with our primary target gene list 
using KEGG pathway annotations (Figure 20). These findings were surprising as 
many of these interactions were predicted or poorly studied. Closer examination 
of links between targets and the ERK signaling pathway might reveal further 
possible interactions. 
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Figure 20. Primary targets are enriched for genes that modulate the ERK signaling pathway. 
 
Figure 20. Primary targets are enriched for genes that modulate the ERK 
signaling pathway.  
Above: Top ranked network cluster from Ingenuity Network analysis of all 
upregulated PTGs. Below: KEGG pathway analysis of upregulated PTGs 
showing significantly enriched pathways.
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 To test if phosphorylation levels of ERK or other signaling pathways were 
altered in the absence of miR-128, we measured levels of total and 
phosphorylated signaling intermediates and kinases using enzyme-linked 
immunosorbent assay (ELISA). Among these, only levels of phosphorylated ERK 
were significantly elevated in Drd1a-cre; miR128-2fl/fl mutant striata (Figure 21a). 
Relating absorbance readings to serial dilutions of control samples suggested 
that mutant samples contained approximately 1.6-fold higher concentration of 
phospho-ERK than controls (Figure 21b). No other assayed phospho-proteins 
(including, JNK/SAPK and AKT kinase) were altered, demonstrating a specific 
effect on ERK pathway activation. 
 Western blot quantification using similarly processed samples 
demonstrated a 1.6-fold increase in phosphorylation levels of ERK2/P42 (Figure 
21c), with no increase in ERK1/P44 phosphorylation (data not shown). We found 
no change in the baseline phosphorylation levels of DARPP-32 Thr34 suggesting 
that that is no increase in levels of dopamine or dopamine receptors or no 
enhanced dopamine receptor activation (data not shown). Similar quantification 
of phospho-ERK from striata of neuronal deletion and overexpression miR-128 
mutants showed that this phenomena was also bidirectionally regulated by miR-
128, consistent with the bidirectionality seen both in the phenotypes of these 
mutants and in the expression of primary targets genes (Figure 21d,e).  
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Figure 21. ERK signaling is enhanced in the absence of miR-128. 
 
Figure 21. ERK signaling enhanced in the absence of miR128. 
a, Increased activation of ERK but not other kinases in Drd1a-cre; miR-128-2fl/fl 
mutants (n=4). Levels of phosphorylated species of kinases indicated were 
quantified from striatal samples by ELISA. 
b, ELISA titration curve using combined control samples show that mutant 
phosphoErk levels are increased 1.65 fold over control. * p<0.05, Welch's t-test. 
c-e, Levels of P42 and phosphorylated P42 were quantified by western blot from 
striatal samples, phosP42 levels were normalized to total P42 levels, P42 levels 
were normalized to "-actin loading controls, and all values expressed relative to 
control mean. Increased P42 phosphorylation in Drd1a-cre; miR-128-2fl/fl mutants 
(c), and Camk2a-cre; miR-128-2fl/fl mutants (d). Decreased P42 phophorylation in 
Camk2a-cre; ROSAmiR-128/miR-128 transgenics overexpressing miR-128 (e). 
Represenative blots are shown. (n=4 each). * p<0.05. ** p<0.01, Welch's t-test. 
All error bars indicate S.E.M.
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4.4 Summary  
 The demonstration of the strong functional significance of miR-128 in D1-
MSNs (previous chapter) presents a relatively homogeneous neuronal 
population in which to isolate miR-128 targets. We have made use of different 
approaches to identify the physiologically relevant targets of miR-128 in vivo 
that exhibit the following properties: (i) 3’UTR association with Ago2 in neurons; 
(ii) presence of miR-128 seed within region of Ago2 association; (iii) significant 
derepression in the absence of miR-128; (iv) bidirectionality of regulation by 
miR-128; (v) regulation by miR-128 in multiple regions of the forebrain. The list 
of primary target genes we identified suggested a role for miR-128 in the 
regulation of ERK-mediated pathways. In agreement with this, we showed that 
uniquely among kinase-mediated signaling pathways, activation of the ERK2 
was sensitively controlled by miR-128. Control of ERK2 by miR-128 is consistent 
with the effect of miR-128 on behavioral excitation. We will examine the possible 
physiological effects of ERK regulation and its contribution to hyperlocomotion 
in the next chapter. 
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Chapter 5: Control of ERK activation by miR-128 in D1-MSNs 
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5.1 ERK signaling in D1-MSNs 
 Extracellular signal-regulated kinases 1 and 2 (ERK1/2) are members of a 
broader family of serine/threonine kinases known as the mitogen-activated 
protein kinases (MAPK), and arguably the best characterized (reviewed in (136)). 
Like all MAP kinases, ERK1/2 are activated by a series of upstream kinases that 
transduce and amplify an initial extracellular or intracellular event. Upstream 
kinases have high substrate specificity, phosphorylating only a restricted subset 
of MAP kinases. In the case of ERK1/2, MAP/ERK kinases 1/2 (Mek1/2) are the 
unique upstream activating kinases.  
 ERK1 (P44) and ERK2 (P42) are nearly identical (85% sequence similarity) 
and universally expressed. However, some important functional differences 
exist. While ERK1-deficient mice display only subtle phenotypic effects (137), 
ERK2 deficiency is embryonic lethal (138). In the adult brain, basal 
phosphorylation and glutamate induced phosphorylation of ERK2 is much 
stronger than ERK1 (139). Furthermore, ERK1 deletion does not appear to affect 
learning ability (140), but mild reductions in ERK2 levels impairs long term 
memory (141).   
 Previous studies showed that the elevation in basal activation of ERK2 
upon miR-128 depletion is consistent with the epilepsy and hyperlocomotion 
phenotypes we observed. Postnatal expression of a constitutively active MEK1 in 
projection neurons resulted in higher phospho-ERK levels and caused 
spontaneous and severe seizures (142). In addition, mice with constitutive ERK1 
deletion show enhanced ERK2 signaling in the striatum and cortex, and 
increased basal horizontal and vertical activity in the open field (139).  
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 The drugs of abuse cocaine and amphetamine strongly induce ERK2 
phosphorylation in the striatum. Induction of ERK2 phosphorylation occurs 
almost exclusively in D1-MSNs and requires activation of both Dopamine D1 
receptors and NMDA glutamate receptors (130, 143). Therefore, ERK2 
phosphorylation mediates detection of coincident dopamine and glutamate 
inputs within D1-MSNs.  
 A number of studies contributed to our current understanding of 
coincident detection (132, 143-145). D1 activation results in phosphorylation of 
Thr34 on DARPP-32 by PKA, which in turn inhibits protein phosphatase 1 (PP1). 
PP1 inhibits STEP, which dephosphorylates ERK (143). D1 receptor activation 
therefore promotes ERK activation by suppressing dephosphorylation. 
Glutamate activation of ERK is less well understood but it is thought to require 
calcium entry via NMDA receptors and Ras-GRF1 (144, 145).  
 ERK2 activation initiates a cascade of phosphorylation events in the 
cytoplasm and nucleus to promote synaptic plasticity and transcriptional 
adaptations that accompany cocaine stimulation. Pre-treatment with MEK1 
inhibitor SL327 at high dose inhibits the locomotor response to acute cocaine 
(146). In addition, paired pre-treatment with SL327 prior to cocaine 
administration abolishes locomotor sensitization (147). These results suggest a 
role for ERK in the regulation of basal excitability as well as the persistent 
changes that result from it. 
 Both high-frequency afferent stimulation and cocaine administration 
induce ERK-dependent long-term potentiation (LTP) in D1-MSNs (148). The 
specific mechanisms that transduce ERK activation into dendritic and synaptic 
potentiation in MSNs are still unclear but are thought to be similar to those that 
 84 
occur in hippocampal neurons. ERK phosphorylation inactivates Kv4.2 
potassium channels (149), which regulate MSN dendritic, and spine excitability 
(128). ERK activity also promotes AMPA receptor insertion at synapses (150, 
151), and increases dendritic branching and spine density in MSNs (152). The 
significance of these mechanisms was demonstrated in a recent study in which 
optogenetic depotentiation of cocaine-potentiated synapses in D1-MSNs was 
sufficient to reverse the expression of locomotor sensitization (148). 
 In the D1-MSN nucleus, cocaine-induced ERK activity promotes 
phosphorylation of MSK1. MSK1 activation in turn activates CREB 
phosphorylation at Ser133 and Histone H3 phosphorylation at Ser10, to induce 
immediate early genes (130, 153). This ERK-dependent transcriptional response 
is an important component of long-term behavioral adaptations, as MSK1 
deficient animals display reduced locomotor sensitization upon repeated cocaine 
administration (153). 
 Aside from these plasticity mechanisms, the regulation of ERK pathway in 
D1-MSNs is also an important component in the pathology of Parkinson's 
disease (PD). In Parkinson's disease, death of midbrain dopamine neurons 
results in loss of dopaminergic tone in the striatum, silencing of D1-MSNs and 
progressive akinesia (154). The study of Parkinson's disease has been greatly 
aided by the use of animal models of Parkinsonian-like dopamine depletion. One 
widely used murine model involves the stereotactic injection of the dopamine 
derivative 6-hydroxydopamine (6-OHDA) into the striatum, where it is taken up 
at dopamine releasing terminals by the dopamine re-uptake mechanism. Uptake 
into cells results in apoptotic death and destruction of nigrostriatal input (155).
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 One well-known epiphenomenon of dopamine depletion is dopamine 
supersensitivity (156), which takes the form of exaggerated behavioral and 
signaling responses to dopamine agonists such as L-dopa. Dopamine 
supersensitivity occurs in response to D1 agonists but not D2 agonists, and 
results in supersensitive activation of ERK and its downstream targets in D1-
MSNs (157). The induction of ERK activation by D1 receptor agonists is very 
mild in normal mice. The requirement for contemporaneous dopamine and 
glutamate inputs to induce ERK phosphorylation might explain this restricted 
response. In the dopamine-depleted striatum however, most D1-MSNs become 
phospho-ERK positive upon stimulation by similar doses of agonist (158).  
 L-dopa induced dyskinesia (LID) is a common and early-noted side effect 
of treating PD with L-dopa (159), which involves a range of abnormal 
involuntary movements which include orofacial and limb dyskinesias. LID has 
been successfully modeled in rat and mouse by chronic L-dopa administration in 
6-OHDA lesioned animals. D1-MSN supersensitivity shares many mechanistic 
similarities with LID. Both acute and chronic administrations of L-dopa in 
lesioned animals induce abnormal activation of the ERK pathway in D1-MSNs 
(158, 160). Furthermore, pharmacological inhibition of ERK during chronic L-
dopa treatment reduces LID (158). 
 The ERK pathway mediates several physiological and pathological 
processes in D1-MSNs. miR-128 regulates steady state ERK activation in D1-
MSNs. In this chapter, we will explore the biological effects of this regulation. 
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5.2 miR-128 suppresses basal electrophysiological excitability of D1-MSNs 
 MAPK activation can result in changes in intrinsic excitability. ERK 
phosphorylation inactivates dendritic potassium channel Kv4.2, changes AMPA 
cycling kinetics to favor increased AMPA receptor insertion and promotes spine 
formation. To examine electrophysiological changes in D1-MSNs in the absence 
of miR-128, we collaborated with Dr. Josh Plotkin at Northwestern University. In 
order to interrogate D1-MSNs specifically we made use of Drd1a-cre; miR128-2fl/fl 
mutant mice expressing eGFP-tagged L10a ribosomal subunit in D1 MSNs (D1-
eGFP-L10a). The eGFP-tagged ribosomes produce a robust green fluorescent 
signal in the nucleolus, allowing for easy identification by fluorescence 
microscopy. Mutant D1-MSNs showed greater dendritic excitability, potentiated 
synaptic AMPA response and increased density of distal spines, consistent with 
the cocaine-induced ERK-dependent effects previously described (Figure 22). 
 Dendritic membrane excitability is measured by the decrease in back-
propagating action potential (bAP) amplitude in distal dendrites compared to 
proximal dendrites upon current injection at the soma. Dendritic membrane 
excitability is believed to be regulated by Kv4.2 voltage-activated K+ channels in 
cortical, hippocampal and striatal neurons. It is also known that Kv4.2 channels 
are inactivated by ERK phosphorylation. Furthermore, Mek inhibition of basal 
phospho-ERK also reduces basal phosphorylation of Kv4.2 and decreases distal 
dendrite bAP amplitude. Therefore, our finding of heightened distal dendritic 
membrane excitability is fully consistent with the increased basal phospho-ERK 
levels. 
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Figure 22. miR-128 suppresses intrinsic excitability of D1-MSNs. 
a, Dendritic excitability is enhanced in D1-MSNs in Drd1a-cre; miR128-2fl/fl; Drd1a-
eGFP-L10a mutants.  Single action potentials were generated in the soma by 
injecting positive current through the electrode.  The evoked calcium transients 
were measured in proximal (~50 µm from soma) and distal (~100-120 µm from 
soma) dendritic shafts by performing synchronized line scans. The attenuation of 
the bAP signal along the dendrite was calculated by dividing the distal calcium 
signal by the maximum proximal calcium signal per cell.  Attenuation was 
significantly enhanced in mutant dendritic shafts.  n=4 cells, 11-21 shafts per 
group.   
b, Synaptic excitability is enhanced. Miniature excitatory post-synaptic currents 
(mEPSCs) were recorded by whole-cell patch recording on control and mutant 
D1-MSNs. 
c, Spine density is increased.  Left: Maximum intensity projection (MIP) images 
of distal (~100 µm from soma) dendrites in control and mutant D1-MSNs.  Right: 
Box plots showing population spine densities.  n=10-11 cells per group.   
d-e, Somatic excitability is unaltered. d, Example responses of a wild type (top) 
and mutant (bottom) D1-MSN to somatic current injections.  Voltage traces are in 
response to -100, -50, +100, +190 and +250 pA. e, Frequency-current (F-I) plot 
showing average firing frequencies to somatic current injection.  No difference 
was observed between WT (N=6) and KO (N=7) dSPNs (Mann-Whitney 
nonparametric test, p>0.05). 
* p<0.05, *** p<0.001, Mann-Whitney nonparametric test. 
Data and figures courtesy of Josh Plotkin.
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Figure 22. miR-128 suppresses intrinsic excitability of D1-MSNs
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5.3 ERK inhibition reverses hyperlocomotion in Drd1a-cre; miR128-2fl/fl 
mutants 
 Cocaine-induced synaptic potentiation in D1-MSN is one major cause of 
locomotor sensitization. Similarly, the increased excitation profile of the miR-128 
depleted D1-MSN might be a likely cause of basal hyperlocomotion of Drd1a-cre; 
miR128-2fl/fl mutants. In this model, mutant D1-MSNs have greater firing 
propensity in response to unchanged endogenous input. If chronic ERK2 
activation is a cause of higher excitability of D1-MSNs, then ERK inhibition 
might be sufficient to normalize basal hyperlocomotion.  
 Systemic administration of SL327 (a blood-brain barrier crossing 
derivative of U0126, a MEK1 inhibitor) resulted in inhibition of locomotion in the 
open field chamber.  We examined the distance traveled in the open field by 
mutants and control mice after injection of increasing doses SL327 and found 
that mutants responded more strongly to SL327 inhibition. At a dose of 
12.5mg/kg, SL327 inhibited activity of mutants with no significant effect on 
controls. To confirm this finding, the experiment was repeated with a second 
cohort of mice. In this experiment, mutants and controls were injected with either 
vehicle (DMSO/Saline) or a 12.5mg/kg dose of SL327. The results clearly show 
that at this low dose, mutant and control locomotion was equalized with no 
change in the activity of control mice (Figure 23b). The experiment was repeated 
and phospho-ERK levels were quantified 30 minutes post-injection, showing that 
baseline ERK activation was also normalized at this dose (Figure 23a). 
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 As SL327 injection resulted in broad inhibition of MEK1, we further tested 
the causative role of ERK in mutant hyperlocomotion using genetic means by 
making use of a previously generated transgenic mouse line with Cre dependent 
expression of dominant negative MEK1 (dnMEK). The dominant negative MEK1 
protein contains a lysine to methionine substitution within the ATP binding site, 
eliminating its kinase activity but preserving the ability to bind ERK1/2.  
 The protein is expressed downstream of a chicken beta-actin promoter 
region and a floxed STOP-cassette, which permits recombinase control of 
expression. We crossed dnMEK transgenic animals with Drd1a-cre; miR128-2fl/fl 
mutants to generate mice in which heterozygous miR-128-2 deletion and dnMEK 
expression occur in D1-MSNs. Total activity in the open field was lower in 
mutants expressing dnMEK, and did not significantly differ from that of wild 
type control mice (Figure 23c). 
 In conclusion, using pharmacological and genetic means of MEK1 
inhibition, we have tested and shown that increased ERK activation had a 
causative role for the hyperactivity observed in the mutant animals in which 
miR-128 was depleted in D1-MSNs. 
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Figure 23. miR-128 modulates motor activity via ERK activation in D1-MSNs. 
a, Increased Erk2 phosphorylation is normalized by low dose Mek inhibitor. 
Drd1a-cre; miR-128-2fl/fl or controls were injected with either vehicle or 12.5mg/kg 
SL327 (n=5) and striata were dissected 30 min later. Right: Phosphorylated P42 
levels were quantified by Western blot, normalized to total P42 levels and 
expressed relative to mean control levels. Left: Representative blot is shown.        
* p<0.05, ** p<0.01, 2-way ANOVA followed by Bonferroni post test. 
b, Basal hyperlocomotion is normalized by pharmacological Erk inhibition. Left: 
Horizontal distance travelled in an open-field chamber in 10 minute intervals. 
Drd1a-cre; miR128-2fl/fl mutants and littermate controls were injected with either 
vehicle or 12.5mg/kg SL327 prior to measurement. (n=16 each group). ** p<0.01, 
two-way repeated measures ANOVA (treatment). Right: Total horizontal 
distance travelled in an open-field chamber over 60 minutes. *** p<0.001, 2-way 
ANOVA followed by Bonferroni post test. 
c, Genetic suppression of Erk2 phosphorylation using conditional transgenic 
dominant negative MEK1 (dnMEK1) rescues basal hyperactivity in Drd1a-cre; 
miR128-2wt/fl heterozygous mutants. Left: Horizontal distance travelled in an 
open-field chamber in 10 minute intervals. Drd1a-cre; miR128-2wt/fl heterozygous 
deletion mutants carrying one transgenic dnMEK1 allele (Drd1a-cre; miR-128-2wt/fl; 
dnMEK1+, n=11), mutants carrying no transgenic alleles (Drd1a-cre; miR-128-2wt/fl , 
n=13) and and wild type controls (n=23) were compared. * p<0.05 ** p<0.01, 2-
way repeated measures ANOVA. Right: Total horizontal distance travelled in an 
open-field chamber over 60 minutes. * p<0.05 ** p<0.01, one-way ANOVA 
followed by Tukey’s post test. 
All error bars indicate S.E.M.
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Figure 23. miR-128 modulates motor activity via ERK activation in D1-MSNs. 
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5.4 miR-128 suppresses supersensitive dopamine response 
 Firing of D1 MSNs induced either by pharmacological activation of D1 
receptors or by direct optogenetic stimulation induces locomotor activity (134). It 
is therefore likely that the hyperlocomotion observed in Drd1a-cre; miR-128-2fl/fl 
mutants reflects a higher population firing rate of D1-MSNs. To test if this 
baseline difference was accentuated, preserved or occluded in the presence of 
further stimulation, we tested the locomotor activity of Drd1a-cre; miR-128-2fl/fl 
mutants in the presence of a D1 receptor specific agonist. Low dose of agonist 
induced locomotor activity in wild type mice, with the peak occurring about 30 
minutes post injection. Interestingly, Drd1a-cre; miR-128-2fl/fl mutants showed an 
even greater locomotor response with a similar duration to peak activity and 
slower return to baseline (Figure 24a).  
 The pharmacological activation of D1-MSNs by cocaine leads to ERK 
signaling activation, phosphorylation of Histone H3 at Serine S10 (H3S10) and 
upregulation of immediate early genes (IEGs) (146, 153). Similarly, D1-MSNs of 
the dopamine-depleted striatum are characterized by a supersensitive ERK 
response, H3S10 phosphorylation, and transcriptional activation in response to 
L-DOPA.   
 Besides basal ERK2 elevation, D1 agonist stimulation induced further 
increases in ERK2 phosphorylation in Drd1a-cre; miR-128-2fl/fl mutants at a dose 
that induced almost no increase in ERK2 phosphorylation in control mice (Figure 
24b). This result suggests that mutant D1-MSNs are supersensitive in a manner 
reminiscent of those in dopamine-depleted striata. 
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Figure 24. miR-128 suppresses supersensitive dopamine response. 
a, Locomotor response to dopamine agonist is heightened by the loss of miR-128. 
Horizontal distance travelled in an open-field chamber shown 5 minute intervals. 
Saline and D1-agonist SKF81297 were injected intraperitoneally 10 and 20 minute 
after introduction to the chamber. Drd1a-cre; miR128-2fl/fl (n=25) and controls 
(n=30). * p<0.05; ** p<0.01; *** p<0.001, Welch's t-test. 
b, Drd1a-cre; miR-128-2fl/fl mutants show supersensitivity of Erk2 phosphorylation 
in response to dopamine agonist. Mutants and controls were injected with either 
saline or D1-agonist SKF81297 (n=5 each) and phosphorylation levels of P42 
were quantified by western blot, normalized to total P42 levels and expressed 
relative to mean control levels. Representative blot is shown. * p<0.05,  two-way 
ANOVA Tukey's post test. 
c-d, Neuronal activation by dopamine agonist is increased by loss of miR128. 
Mutant (Drd1a-cre; miR128-2fl/fl; Drd1a-eGFP-L10a) and control mice (miR128-2fl/fl; 
Drd1a-eGFP-L10a) are injected with either saline or agonist and sacrificed 30 
minutes later and total striatum is dissected for flow cytometry. c, Representative 
nuclei counts showing eGFP-positive D1-MSN nuclei and activation as assayed 
by phosphorylated Histone H3S10. d, Number of activated D1 MSN nuclei was 
counted and expressed as percentage of total D1 MSN nuclei. Each symbol 
represents sample for one mouse. * p<0.05, 2-way Anova followed by Tukey’s 
post-test. 
e-f, Transcriptional activation by dopamine agonist is increased. Mutant (Drd1a-
cre; miR128-2fl/fl; Drd1a-eGFP-L10a) and control mice (miR128-2fl/fl; Drd1a-eGFP-
L10a) were injected with either saline or agonist and sacrificed 30 minutes later 
and polysome-associated transcripts were quantified by either microarray or 
qRT-PCR. e, Hierarchical clustering was performed on probes corresponding to 
immediate-early genes (IEG). Only agonist-injected samples cluster according to 
genotype. f, Selected immediate early genes and Darpp32 were quantified by 
qRT-PCR from polysome associated transcripts and expressed relative to control 
saline samples. ** p<0.01, *** p<0.001, 2-way ANOVA followed by Tukey’s post-
test. All error bars indicate S.E.M.
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Figure 24. miR-128 suppresses supersensitive dopamine response. 
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 To extend this observation, we tested if locomotor and ERK 
supersensitivity is accompanied by potentiated histone phosphorylation and 
transcriptional response. Using Drd1a-cre; miR-128-2fl/fl mutants and control mice 
expressing tagged ribosomes in D1-MSNs - Drd1a-cre; miR128-2fl/fl; Drd1a-eGFP-
L10a, we were able to assay the extent of these responses in a cell-specific 
manner.  
 To quantify H3S10 phosphorylation, we enlisted the help of Dr. Melanie 
von Schimmelmann. EGFP-positive nucleoli in the nuclei of D1-MSNs allow 
quantification of histone activation in the D1-MSN population. Drd1a-cre; 
miR128-2fl/fl; Drd1a-eGFP-L10a mutants and controls were injected with either 
saline vehicle or D1 agonist SKF81297. Animals were sacrificed 30 minutes later 
and striata dissected and nuclei were isolated. Nuclei were then incubated with 
antibodies against phosphorylated H3S10 and processed for flow cytometry. 
Agonist induction resulted in a higher percentage of phospho-H3S10 positive 
D1-MSNs (Figure 24c,d). 
 To quantify transcriptional activation, Drd1a-cre; miR128-2fl/fl; Drd1a-eGFP-
L10a mutants and littermate controls were injected with either saline vehicle or 
D1 agonist SKF81297. Animals were sacrificed 30 minutes later and striata 
rapidly dissected and processed for polysome immunoprecipitation and RNA 
isolation followed by microarray analysis. IEGs were defined as genes 
upregulated in control mice by at least 5 fold in response to agonist (19 unique 
genes). Cluster analysis of IEG expression levels show that mutant samples 
segregated from control samples upon agonist injection (Figure 24e). Based on 
two-way ANOVA analysis, aggregate IEG expression levels were higher in 
mutants than controls upon induction, confirming greater transcriptional 
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activation. Selected IEGs were quantified further by qRT-PCR and these showed 
significantly higher agonist-induction in mutants (Figure 24f).  
 We have shown earlier that miR-128 overexpression suppresses 
endogenous ERK activation. We therefore tested if excess miR-128 suppresses the 
development of behavioral supersensitivity. Firstly, transgenic mice 
overexpressing miR-128 showed a reduced locomotor response to acute D1-
agonist administration, with similar induction kinetics (Figure 25a).  
 We further tested if miR-128 could suppress supersensitive responses in 
the hemiparkinsonian mice model. To do this, we made use of an assay of 
rotational behavior in unilateral 6-OHDA lesioned mice. In this model, both the 
extent of denervation and D1-MSN supersensitivity can be assayed by 
quantifying rotational behavior. Systemic administration of cocaine results in 
ipsilateral rotations toward the side of the lesion due to the imbalance of 
dopamine releasing terminals, while systemic administration of either L-dopa or 
D1 receptor agonist, result in contralateral rotations due to supersensitive 
responses in the lesioned striatum (156) (Figure 25b). 
 We performed unilateral lesions of transgenic mice in which 6-OHDA was 
stereotactically injected into the left striatum and vehicle was injected into the 
right striatum. After a 3-week recovery period, rotational responses were 
quantified. Mice did not result in net rotations in either direction at baseline. 
Cocaine injection led to similar net ipsilateral rotations in control and transgenic 
mice. In contrast, upon D1 agonist injection, transgenic mice showed lower net 
contralateral rotation compared to controls indicating reduced D1-MSN 
supersensitivity (Figure 25c). 
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Figure 25. Transgenic miR-128 expression suppresses excitability. 
 
Figure 25. Transgenic miR-128 expression suppresses excitability. 
a, Locomotor response to dopamine agonist is dampened by increased miR-128. 
Horizontal distance travelled in an open-field chamber shown 5 minute intervals. 
Saline and D1-agonist SKF81297 were injected intraperitoneally 20 and 40 minute 
after introduction to the chamber. Camk2a-cre; ROSAmiR-128/miR-128 and controls 
(n=11 each). * p<0.05, ** p<0.01, Welch's t-test. 
b-c, Unilateral 6-OHDA lesions were performed on Camk2a-cre; ROSAmiR-128/miR-128 
and control mice, by stereotactic injection into the left striatum. Vehicle injections 
were performed on the right striatum.  Rotational responses to cocaine and D1 
agonist SKF81297 were measured after a 3 week recovery period.  
b, Cocaine injection induces ipsilateral rotations due to presence of functional 
dopamine terminals in the unlesioned striatum. SKF81297 induces contralateral 
lesions due to increased dopamine response of D1-MSNs in the lesioned 
striatum. c, Overexpression of miR-128 suppresses contralateral rotation in 
response to D1 agonist. (n=10 per genotype) ** p<0.01 Welch’s t-test. All error 
bars indicate S.E.M.
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5.5 miR-128 depletion impairs learning and memory 
 ERK-dependent changes are crucial to synaptic and transcriptional 
mechanisms of plasticity and the loss of ERK signaling impairs animal 
performance in memory tasks and the ability to acquire new associations.  
 In cocaine-conditioned place preference (CPP), cocaine administration is 
paired with a specific context during training phase. At the test phase, test 
subjects are allowed to roam freely between cocaine and saline-paired chambers. 
Successful conditioning results in substantially more time spent in the cocaine-
paired chamber due to the rewarding effects of cocaine (Figure 26a). Inhibition of 
ERK activation during conditioning abolished place preference (146), while in 
models with enhanced ERK2 signaling, mice showed increased cocaine 
sensitization and increased CPP responses (161). Therefore, we tested if Drd1a-
cre; miR128-2fl/fl mutants have higher CPP responses too. We found that these 
mutants show a significantly reduced CPP response compared to controls, as 
shown by the lower duration spent in exploration of the cocaine-paired chamber 
(Figure 26b). 
 To examine this effect further, we examined the performance of miR-128 
depleted mutant mice in a separate behavioral task. In the novel object 
recognition task, experimenters make use of the robust, innate rewarding effects 
of novelty to produce a heightened exploratory response. This behavior is 
analogous to the novelty-induced hyperactivity upon inital exposure to the open-
field chamber. In this paradigm, mice are trained by exposure to two identical 
objects in a chamber to which the mice have been previously acclimated. At 1 
hour and 24 hours after training, test phases are conducted in which one of the 
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objects is replaced by a novel object prior to the introduction of the test subject 
into the chamber. Mice spend more time in exploration directed toward the novel 
object compared to the training object, indicating retention of memory of the 
trained object (Figure 26c). ERK suppression by hippocampal injection of MEK1 
inhibitor during the training phase spares short-term memory (10min post-
training) performance but severely impairs long-term memory (24 hours post-
training) (162).  
 As the majority of homozygous Camk2a-cre; miR-128-2fl/fl mutants suffer 
from frequent seizures and die before 2 months of age, we performed this test on 
heterozygous Camk2a-cre; miR-128-2wt/fl mutants. Both mutant and control mice 
spent equal time exploring both objects during the training phase and 
significantly increased novel-object exploration during the 1 hour test phase. 
Interestingly, mutant mice showed severe impairments during the 24 hour test 
phase (Figure 26d). 
 Since ERK inhibition impairs acquisition and retention of learned 
associations, we expected that increased ERK sensitivity of miR-128 mutants 
would exhibit improved performance in learning and memory tasks. The reasons 
for this discrepancy will be discussed in the final chapter. 
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Figure 26. miR-128 depletion results in learning and memory deficits. 
a, Schematic shows cocaine place preference in a 3-chamber test set-up. During 
test phases, mice are placed in center chamber and allowed to freely explore all 3 
chambers for 5 minutes. During conditioning, mice are injected with either saline 
or cocaine (15 mg/kg) and placed in the correspondingly paired chamber for 15 
minutes. The other pairing is performed 4 hours later. This conditioning protocol 
is repeated daily for 3 days. Free exploration test is performed on the 4th day. 
b, Drd1a-cre; miR128-2fl/fl mutants are less efficiently conditioned by cocaine. Ratio 
of duration spent in cocaine-paired chamber to duration spent in saline-paired 
chamber is shown. 
(n=12 per group). ** p<0.01, 2-way ANOVA followed by Bonferroni post test. 
c, Novel object recognition task. During training phase, mice are allowed to 
freely explore a chamber with 2 identical objects. Mice are tested for recognition 
memory at 1 hour and 24 hours after training phase, with replacement of one of 
the training objects in each case.  
d, Camk2a-cre; miR-128-2wt/fl heterozygous mutants are impaired for long-term 
memory object recognition memory. Line graphs show time spent exploring the 
novel object as proportion of total time spent exploring both objects. (n=15 per 
group) ** p<0.01, 2-way ANOVA followed by Bonferroni post test.  
All error bars indicate S.E.M.  
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Figure 26. miR-128 depletion results in learning and memory deficits. 
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5.6 Summary  
 In summary, miR-128 loss induces basally elevated ERK2 signaling in D1-
MSNs and the inhibition of ERK2 was sufficient to rescue basal hyperactivity, 
probably via ERK-dependent increases in neuronal excitability. In the absence of 
miR-128, D1-MSNs exhibit behavioral and ERK signaling supersensitivity similar 
to that which develops after dopamine depletion. This is also accompanied by a 
similar supersensitive transcriptional response. Furthermore, miR-128 
overexpression was able to suppress behavioral supersensitivity. Lastly, we 
examined the performance of miR-128 mutants in learning and memory tasks 
and showed that their performances were strongly impaired, suggesting that 
ERK signaling hyperactivation does not necessarily enhance learning and 
memory. 
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Chapter 6 Discussion  
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6.1 Summary of findings 
 In this section, I will first summarize the key findings of the work 
presented here and subsequently expand on a few specific topics in separate 
sections.  
 We have demonstrated that segregated miRNA expression across 
neuronal types in the adult brain has enormous functional consequence. Prior 
studies found strong enrichment of miR-128 in projection neurons relative to 
interneurons of the forebrain. We demonstrated that the deletion of miR-128 in 
the former alone was sufficient to recapitulate fully the fatal epilepsy and severe 
hyperactivity observed upon ubiquitous deletion. We further extended this 
finding by showing that miR-128 is enriched in D1-MSNs over D2-MSNs of the 
striatum and that deletion of miR-128 in the former but not the latter was 
sufficient to recapitulate fully the hyperactivity induced by striatal deletion of 
miR-128.  
 By employing a combination of tools to identify RISC-associated 
transcripts and translationally repressed transcripts, we were able to isolate 
primary targets of miR-128 repression in an unbiased manner. This strategy 
allowed us to identify a relevant pathway (ERK signaling), the specific 
dysregulation of which accounts for some aspects of the behavioral changes. Our 
results strongly suggest that such a strategy would be very useful in other 
studies of miRNA function. 
 Finally, we showed that endogenous miR-128 expression suppresses ERK 
pathway activity and limits the excitability of neurons. This in turn could explain 
the development of spontaneous, fatal seizures and severe hyperactivity upon 
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miR-128 deletion. miR-128 suppresses a ERK hypersensitive response to 
dopamine and represses the supersensitivity of D1-MSNs in the dopamine-
depleted striatum. This effect suggests clinical use to miR-128 in the treatment of 
neurological disorders in which hyperexcitability plays a major role, for example 
epilepsy and L-dopa induced dyskinesia. 
 In the following sections, I will discuss our miRNA target search strategy 
and other methods that might offer an improvement over the one we have 
employed. I will discuss the implication of ERK regulation by miR-128 for 
plasticity and learning, as well as possible roles of this regulation in other cell 
types. Finally, I will suggest further studies that might clarify the role of miR-128 
in human dyskinesias and epilepsy. 
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6.2 In-vivo tools for primary target identification 
 In our search of physiologically relevant targets of miR-128, we have 
made use of two complementary tools: Ago2 CLIP-seq to profile RISC-associated 
mRNAs and TRAP-ribosomal profiling to profile transcript derepression in the 
absence of miR-128. This approach is a considerable improvement over 
methodologies used in previous studies undertaken to identify miRNA targets, 
mostly involving mRNA quantification.  
 MiRNA-dependent repression of target expression involves translational 
inhibition (reduced ribosomal association) and mRNA degradation (reduced 
mRNA quantity). These two processes are largely correlated but not necessarily 
linked, as such, quantification of ribosomal association is less restrictive and 
would include translationally-repressed transcripts for which no reduction in 
mRNA levels occur.  
 Ribosomal profiling experiments have previously been used in the study 
of miR-223-mediated repression in culture-differentiated neutrophils (79). The 
use of tagged ribosomes in TRAP technique allows cell-type specific expression 
profiling on rapidly dissected brain tissue and improves experimental resolution 
by excluding non-cell autonomous expression changes.  
 Other alternatives to ribosomal profiling include protein quantification 
using metabolic labeling experiments (163). However, such experiments are as 
yet difficult to implement in living animals (164), are also just beginning to be 
implemented in a cell-type specific manner (165) and is likely to offer only 
marginal improvements over ribosomal profiling. 
  
 108 
 Expression changes upon miRNA loss reflect not just the primary 
derepression of primary targets, but also the extensive secondary changes that 
invariably accompany chronic miRNA loss. To sieve out primary targets from 
secondary changes, in-silico predicted targets are often used. This approach 
depends greatly on the presence or absence of conserved complementary seed 
sequences in the altered transcripts, without evidence for whether such sites do 
indeed confer RISC association. Our method uses physiological RISC binding to 
identify primary targets.  
 All binary classification methodologies necessarily involve a trade-off 
between false positive rate and false negative rate. Because most if not all targets 
are repressed by miRNAs, and derepression of single targets are highly similar, 
changes in mean derepression can be used as a proxy of false positive rate. High 
mean derepression of a candidate target upon miRNA loss correlates with low 
false positive rate. By this measure, the use of CLIP-seq positive 6mer-containing 
targets as we have done produces a lower false positive rate than the use of all 
6mer-containing targets in the genome. The use of conserved Targetscan 
predictions appears to produce an even lower false positive rate. However, 
previous studies have shown that non-conserved sites are also highly responsive 
to miRNAs, suggesting that limiting by conservation scores is too restrictive. 
 False negatives are more difficult to estimate from our data, but could 
arise in a number of situations. In some cases, full seed complementarity is not 
an absolute requirement for miRNA binding if non-canonical interactions exist 
along the rest of the miRNA. Future iterations of CLIP-seq might include such 
possibilities. However, the sequence determinants of such of "extra-seed" 
interactions are less well-defined and previous estimates suggest such pairings 
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are relatively rare. A more important source of false negatives is the detection 
limit imposed by RNA-sequencing. This group of false negatives would include 
target transcripts that are expressed at very low quantities, and transcripts of 
which only a small proportion are bound to the RISC-complex. Repeating the 
protocol using higher sequencing depth would address this issue to some extent. 
 In summary, we have used more physiological measures of derepression 
and RISC association, which allows us to reduce false positives without arbitrary 
sacrifices in sensitivity. New techniques in protein level quantification and the 
incorporation of known cis-determinants of targeting are likely to improve this 
process. New insights about miRNA-RISC biology might be gleaned from a 
quantitative and global view of miRNA targeting and repression. 
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6.3 Tuning and buffering of targets and ERK signaling 
 We have shown that primary target genes, in aggregate, respond in a 
bidirectional fashion to depleted and excess miR-128 levels. Most of these genes 
show a very mild repression by miR-128 in line with the fold changes observed 
by other groups. As transcription is an inherently noisy process, it is difficult to 
see how such mild changes could persist in single cells in the presence of 
stochastic fluctuations.  In this and previous studies, the measured repression is a 
population mean of large cell populations, what remains unclear is if miR-128 
repression has an effect on population variance. This could be determined by 
quantifying mRNA levels in single neurons or estimated using bins of small 
fixed numbers of neurons. If the mild repression level is a result of miR-128 
buffering of stochastic transcriptional noise, one would expect the population 
variance of target expression to be increased substantially in the absence of miR-
128. Conversely a strict tuning effect would preserve temporal variability in each 
neuron and preserve variability across the population of neurons.  
 We have also shown that miR-128 levels exert a specific and bidirectional 
regulation of ERK2 phosphorylation, although it is similarly unclear how the 
profile of the response is altered. 
 ERK signaling response is highly cooperative in Xenopus oocytes and in 
in-vitro systems (166, 167), converting graded signals into an all-or-none 
response. In mammalian cells, a switch-like response is found in thymic selection 
and neuronal differentiation (168, 169), while a more graded response is 
observed in other conditions (170). Increased steady-state phosphorylation levels 
in D1-MSNs might occur through a number of ways: decreased cooperativity, 
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reduced threshold for activation, or increased background by independent 
processes, or a mixture of the above.  
 Additional experiments to address this question could be performed in 
striatal slice cultures. Steady state phospho-ERK levels in striatal slices exposed 
to different levels of glutamate or KCl can be quantified for control and D1-
mutant slices. These experiments could clarify which subsets of primary targets 
exert the greatest contribution to elevated steady state ERK signaling. 
 In conclusion, examination of population variance of miR-128 targets and 
examination of the population variance and input-dependence profile of ERK 
signaling are both interesting avenues to examine in detail the key primary 
effects of miR-128 regulation. 
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6.4 ERK signaling in neurons and the regulation of excitability 
 Among the electrophysiological consequences of miR-128 loss in D1-
MSNs, we found a substantial increase in dendritic membrane excitability. 
Intrinsic dendritic or neuronal excitability is increasingly thought to be a vital 
mechanism of metaplasticity - processes which alter the ability to generate 
synapse-specific plasticity (LTP or LTD) (171, 172). Kv4.2 regulation of dendritic 
branch excitability itself could be a form of persistent information-encoding 
change that allows specific input-patterns to promote persistence of LTP at 
synapses on the branch (173, 174). A similar process appears to occur in D1-
MSNs. Coordinate excitatory inputs induce an "up-state" characterized by 
depolarized distal dendritic potential, during which LTP induction is enhanced. 
D1 receptor activation enhances distal excitability and increases the duration of 
these "up-states".  
 A change in excitability is sufficient to account for the altered behaviors 
observed in Drd1a-cre; miR128-2fl/fl mutants. 1. Endogenous inputs would 
produce a higher firing probability that is sufficient to trigger locomotor activity, 
thus accounting for basal hyperlocomotion. 2. Longer "up-state" durations could 
enhance NMDA receptor activation that is required of ERK activation. This could 
account for the apparent ERK hypersensitivity upon D1 agonist stimulus.  
 Our results studying the effects of miR-128 on learning and memory 
provide important clues as to the role of miR-128 in ERK regulation. While the 
general dis-inhibition of ERK signaling potentiates intrinsic excitability and 
transcriptional responses, pairing of cocaine-induced dopamine signaling with 
contextual information is impaired. In light of the role of ERK in coincident input 
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detection I would venture to speculate that miR-128 loss produces a fundamental 
dysfunction of ERK signaling such that these signals no longer adequately 
represent and transduce external information. For example, "up-states" in D1-
MSNs might be dissociated from cortical inputs that carry information about the 
context. In this model, ERK supersensitivity and enhanced transcriptional 
response enhances the induction of plasticity mechanisms. However, ERK 
activation could be "noisy" and become engaged even in the absence of 
physiological inputs, resulting in the strengthening of "inappropriate" synaptic 
associations. 
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6.5 miR-128 in other contexts 
 Given that miRNA targets are highly dependent on cellular context, it is 
unclear if miR-128 has a similar role in regulating ERK in other cell and tissue 
types. That being said, the known miR-128 expression in some specific cell types 
suggests that ERK regulation might be a significant component of miR-128 
function in these specific contexts as well. I will highlight some of these examples 
below and speculate on the possible roles play by miR-128. 
 Thymocyte development is the process of producing of mature T 
lymphocytes that are able to respond to foreign antigens and are tolerant of self 
antigens. Within the thymus, immature thymocytes pass through a number of 
specific stages identifiable by surface markers, which correlate with a number of 
important processes such as gene rearrangement and positive and negative 
selection.  
 Both miR-128 and its host gene TARPP are strongly upregulated 
beginning at the DN3 stage, reaching a maximum during the DN4 stage (175, 
176). At the DN3 stage (CD4-CD8-CD44-CD25+), thymocytes initiate 
rearrangement of the TCR" loci. Productive rearrangement leads to its 
expression in a complex with the alpha-T cell receptor (pre-TCR). This 
developmental stage coincides with beta-selection and #"/$% lineage 
divergence, both of which depends on pre-TCR signals which are transduced 
primarily by ERK signaling. It has been shown that the strength of ERK signaling 
downstream of pre-TCR provides an instructive signal for the commitment to the 
#" or $% lineage (177, 178). A strong ERK signal favors $% lineage differentiation 
while the opposite favors #" lineage commitment.  
 115 
 In light of this model, the expression of miR-128 suppresses the signaling 
response to favor #" lineage commitment. In agreement with this, our 
preliminary data suggests that constitutive deletion of miR-128 results in a small 
increase in the population of $% positive T cells in the thymus. 
 Conversely, miR-128 expression begins to decrease in the DP stage 
(CD4+CD8+). Among the vital thymic selection processes that occur in this stage 
is positive selection, in which functional #" TCR-MHC (major histocompatability 
complex) interaction results in an instructive signal that permits further 
maturation. Intracellular signaling during positive selection is transduced by the 
ERK pathway. Transition of DP thymocytes into a ERK hypersensitive condition 
is required for the amplification of weak TCR-MHC signals and for positive 
selection (179). Indeed, loss of the transcriptional program required to induce 
this ERK hypersensitivity results in failure of positive selection. In this model, 
miR-128 reduction might coincide with and contribute to the induction of ERK 
hypersensitivity. 
 Leukemia is a form of cancer characterized by uncontrolled increase in 
circulating white blood cells. Among acute forms of leukemia, acute 
lymphoblastic leukemia (ALL) is derived from lymphocytic precursors, which 
also give rise to thymocytes, while acute myeloid leukemia (AML) is derived 
from precursors of red blood cells and platelets. 
 miRNA profiling of ALL and AML samples and cell lines show that miR-
128 is among the most differentially expressed among the 2 groups (180). High 
miR-128 DN4 stage is also highly proliferative, so at minimum miR-128 might 
not be tumor suppressing in the lymphoblast lineage, as is the case in other 
cancers. It might be interesting to speculate that commitment to the 
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lymphoblastic lineage confers changes that permit oncogenic property of miR-
128 in ALL or reduce the tumor suppressing effects in ALL. 
 The tumor suppression properties of miR-128 is better characterized in 
other cancers, and has been studied as a potential therapeutic tool. For example, 
low miR-128 levels correlate with aggressive gliomas. miR-128 is shown to 
suppress stem-cell renewal factor Bmi-1 and reduce glioma proliferation (181). In 
another study, miR-128 suppresses oncogenic receptor tyrosine kinases to 
suppress proliferation and enhance differentiation (182). As ERK and MAP 
kinase signaling are key transduction events downstream of receptor tyrosine 
kinases, it might be possible that a broader examination of miR-128 targets in 
gliomas might identify further nodes of regulation. 
 In summary, our finding that miR-128 exerts a sensitive control of ERK 
signaling might be informative about the role of miR-128 in other contexts in 
which ERK signaling is an important transducer of external signals. 
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6.6 miR-128 in Parkinson's disease and human epilepsy 
 We have shown that substantial similarities exist between the D1-MSN 
hyperexcitability in miR-128 mutants and that induced upon dopamine 
depletion. D1-MSN hyperexcitability develops soon after dopamine depletion 
and persists even after dopamine replacement for example upon chronic L-
DOPA treatment. However, the primary cause of this phenomenon is not well 
understood. Further experiments could address if miR-128 depletion occurs 
upon dopamine depletion and if this might be a primary cause of ERK 
hypersensitivity in this pathological condition. As post-depletion D1-MSN 
hyperexcitability is thought to share mechanisms that lead to the development of 
L-DOPA induced dyskinesias, this has clear clinical implications for the 
treatment of Parkinson's disease. 
 The fact that reduced miR-128 can lead to pronounced epilepsy in mice 
suggests that miR-128 and its target genes might contribute to genetic 
predisposition in human epilepsies. Human idiopathic epilepsies have a 
substantial genetic component, with an estimated heritability of over 80% from 
twin studies (183). While rare cases of genetic epilepsy have monogenic 
determinants (184), mostly involving mutations in voltage- or ligand-gated ion 
channels, the vast majority of idiopathic epilepsies are presumed to have 
complex polygenic causes and significant genetic-environmental interactions.  
 A common method for the identification of major susceptibility genes is 
the use of linkage mapping and positional candidate gene analysis but most 
studies have focused on protein coding genes included within the linkage region.  
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 To see if miR-128 could be a susceptibility gene, I looked for studies that 
found linkage regions overlapping with one or both of the human miR-128 loci. 
In one analysis of childhood absence epilepsy involving over 300 individuals 
from 63 families, the authors found a large linkage region spanning 3p23-3p14, 
which overlaps with human miR-128-2 (185). In a separate study, the authors 
analyzed members of a multi-generation family presenting with autosomal 
dominant generalized epilepsy. This study found significant linkage in a much 
narrower region that also overlaps with human miR-128-2 (186). Interestingly, 
the epileptic condition in this family is accompanied by mental retardation, in 
agreement with the learning and memory deficits we observed in our miR-128 
mutants. These studies suggest that genetic mutations resulting in aberrant miR-
128 sequence or miR-128 expression might be a primary determinant in these 
cases. 
 Follow-up studies might be complicated by the small size of miRNAs, and 
by the fact that mutations in the hairpin are likely to be strongly deleterious. 
Instead, mutations are much more likely to cause expression changes. Besides 
mutations in the host gene promoter, mutations that alter the tertiary and 
secondary structure of the hairpin region and mutations that affect Drosha 
processing could also result in reductions in mature miR-128 levels. This makes 
the demonstration of a causative allele involving miR-128 particularly 
challenging, especially in the absence of a strong candidate allele. 
 Whether miR-128 is a naturally occurring epilepsy determinant or a cause 
of D1-MSN hyperexcitability, our data suggests that miR-128 expression might 
have therapeutic value. Such a treatment might require a mechanism to increase 
specificity to projection neurons to avoid potentially deleterious overexpression 
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in interneuron populations. Further experiments overexpressing miR-128 in local 
interneuron populations would help to identify these adverse effects if they do 
exist. 
 In conclusion, our findings presented here could have substantial 
implications for future clinical and therapeutic research.
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Material and Methods 
Mice 
All procedures involving animals were performed in accordance with the 
National Institutes of Health Guide for the Care and Use of Laboratory Animals 
and were approved by the Rockefeller University Institutional Animal Care and 
Use Committee. All mice were generated and maintained in C57BL6/J 
background. 
 
Generation of mice with neuron-specific tagged-Ago2 expression. 
Transgenic mice expressing a Cre-inducible FLAG-HA2-tagged Ago2 under the 
control of the Rosa26 promoter were generated as previously described (Schaefer 
et al., 2010; Sasaki et al., 2006; the STOP-eGFP-ROSA26TV vector was a gift from 
K. Rajewsky, Harvard Medical School, Boston, MA). Rosa-Stop fl/fl-Flag-Ago2 
mice were bred to Camk2a-Cre (provided by G. Schuetz, German Cancer 
Research Center, Heidelberg, Germany;) (126) , Drd1-Cre (EY262) and A2a-Cre 
(KG139) transgenic mice obtained from Gensat (187) to generate Camk2a-Cre; 
Rosa26-Ago2-Flag , Drd1-Cre; Rosa26-Ago2-Flag, and Drd2-Cre; Rosa26-Ago2-
Flag mice.  
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Generation of mice with a conditional deletion of miR128-1 and miR128-2.  
Subcloning of targeting vectors  
A region of the miR-128-1 or miR-128-2 genomic locus containing the arms of 
homology was recombinogenically subcloned from a BAC clone (miR-128-1: 
RP24-574G14, miR-128-2: RP24-242F13, C57Bl/6J, CHORI, Oakland CA, USA) 
into pBlueScriptIIKS+ as described (188), using amplicons that insert an AscI site 
and a XhoI site to flank the subcloned region.   
PCR primers used for subcloning:  
mir-128-1  
5' ccttcatgttatgccctcatccctttatcacacaaatctgtgtagttttcggcgcgccattcgccctatagtgagtcg  
5' aatcttctaaatttccatttgagcacctagttcatatgtaatttagattcctcgaggcttggcgtaatcatggtc  
mir-128-2  
5' cgaaaaatattttcatttattcttcgaaactttcatacattcatacaatgtggcgcgccattcgccctatagtgagtcg  
5' tcaggcctgccagccttctgtctactgtttaatgactgacagccagtgaactcgaggcttggcgtaatcatggtc  
 
Modification of targeting vector for miR128-1  
pZeroloxP-FRT-neoR-FRT(-) plasmid was modified to replaced unique EcoRI site 
with unique SmaI site. Modified plasmid was digested with NsiI and fragment 
containing single loxP site and FRT-flanked neo gene was inserted into unique 
NsiI site in targeting vector and screened to proper orientation. For insertion of 
second loxP site, oligonucleotide fragments containing loxP sequences were 
annealed and inserted into the unique SpeI site:  
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Modification of targeting vector for miR128-2  
pZeroloxP-FRT-neoR-FRT(-) plasmid was modified to introduce SmaI sites by 
insertion of oligonucleotide fragments at the SacI/ApaI site and at the Acc65I 
site. Modified plasmid was digested with SmaI and fragment containing single 
loxP site and FRT-flanked neo gene was inserted into unique SmaI site in 
targeting vector and screened to proper orientation. For insertion of second loxP 
site, oligonucleotides containing loxP sequences were annealed and inserted into 
a unique HindIII site. 
 
Homologous recombination 
For both targeting vectors, modified regions of homology were excised from 
pBluescript with XhoI and AscI digests and inserted into similarly digested 
pDTA-TK to produce final targeting constructs. Targeting constructs were 
linearized with NotI and E14 CY2.4 embryonic stem cells (homozygous 
C57Black/6JTyr-C-2J background with natural mutation in tyrosinase gene) were 
transfected and screened for successful recombination using southern probe. 
Positive clones were confirmed using an alternative Southern probe and by PCR 
sequencing of modified region. Positive clones were used to produce chimeric 
mice as described. Chimeras were crossed to C57BL6/J mice and germline 
transmission was assessed by coat color, PCR and southern blot analysis. 
Germline deletion of the FRT-flanked neo gene was accomplished by crossing 
mice carrying the targeted alleles with FLPe- transgenic mice (3). Germline 
deletion of miR-128-1 and miR-128-2 was achieved by crossing mice carrying 
floxed alleles to transgenic mice that express Cre-recombinase under the 
ubiquitously expressed CMV promoter (CMV-Cre mice, Jackson Laboratory). 
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Postnatal, neuron-specific deletion in the mouse forebrain was achieved by 
breeding mice carrying floxed alleles to Camk2a- Cre mice (126). Drd1-Cre (EY262) 
and A2a-Cre (KG139) transgenic mice were obtained from Gensat (187) and Drd1-
Cre; miR128-2fl/fl mice and A2a-Cre; miR128-2 mice were generated by breeding 
to miR128-2fl/fl mice.  
  
PCR Genotyping 
Routine genotyping of miR-128-1 mice was performed using following primers:  
5' tctggaccaaatgaaccaaag  
5' ccgcaatgctgcctatattc  
5' gcctgaagaacgagatcagc  
5' gcagtcatgcaagcagctat  
Wild type allele: 194bp  
Null allele: 282bp  
Floxed allele: 336bp  
Routine genotyping of miR128-2 mice was performed using following primers:  
5' cgccttttagtttcccacag  
5' gaccacacagcaagcaggta  
5' aaagacgggaccattcacat  
5' tctctcgtgggatcattgttt  
Wild-type allele: 185bp  
Null allele: 531bp  
Floxed allele: 306bp  
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Generation of mice with a neuron-specific overexpression of miR-128 
Targeting vector for homologous recombination at the ROSA26 locus was 
generously provided by K. Rajewsky. A 1kb region including miR128-2 hairpin 
was amplified from genomic DNA with the following primers and cloned into 
unique xhoI site in the targeting vector: 
5’ aaaggcgcgccacgtgactaaaaggcgcgaggagat 
5’ aaaggcgcgcctacgcattcctgtacggttg 
Modified targeting vector was linearized by NotI and used to generate chimeras 
as above. Successful germ line transmission was assessed by coat color and 
confirmed by PCR and southern analysis. Postnatal, neuron-specific miR-128-2 
overexpression in the mouse forebrain was achieved by breeding mice to 
Camk2a- Cre mice (126). 
 
CLIP-seq analysis 
In vivo Cross-Linking and ImmunoPrecipitation (CLIP) procedure. 
Mice were sacrificed at 8 to 14 weeks; forebrains were excised and triturated to 
disrupt tissue. Immunoprecipitation on the UV-crosslinked triturated tissues was 
performed as described (61) with the following modifications to the protocol: 
After UV cross-linking the frozen lysates are sonicated to improve tissue 
homogenization. RNase digestion with RNase A is done twice during out 
protocol once before IP (using one fourth the concentration of RNAse A used by 
Chi et al) and once after IP (using one twentieth the concentration of RNAse A 
used by Chi et al). 30µl magnetic beads pre-coupled to the M2 FLAG antibody 
(M8823, Sigma) have been used for each IP on half a forebrain in 1.2 ml after pre-
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blocking the beads with 2% BSA, 1% t-RNAs and 1% salmon sperm for 1.5 hrs at 
4o C. Unlike Chi et al. we did not transfer RNA-protein conjugates to a membrane 
during RNA purification and we did not use hot labeled adapters in the 
preparation, instead RNA was directly decrosslinked from protein after 
extensive washing. 
 
Illumina Sample Preparation and Sequencing. 
The small RNA sample preparation kit, version 1.5 (Illumina) was used for 
library preparation with subtle modifications. Since low concentrations of RNA 
was purified from the CLIP procedure, as measured by Quant-iT RiboGreen 
RNA Assay (Invitrogen), the following modifications were made to the small 
RNA sample preparation kit (Illumina) to allow for extremely low RNA input: 
Both the v1.5 sRNA 3’ Adapter and the SRA 5’ Adapter were diluted 10 times in 
nuclease-free water compared to standard protocol before adapter ligation. The 
RT reaction was doubled (resulting in a final RT volume of 20 µl instead of the 
standard 10 µl), all of which was used for the downstream PCR reaction. To 
allow for the larger volume of RT product 10 µl less water was used in the PCR 
step, resulting in a final PCR volume of 50 µl. Instead of the 12 cycles of PCR 
directed in the standard protocol 15 cycles were performed to increase output. 
Preparation of RNA for sequencing was performed in two sets: First, four Ago2-
Flag and two control CLIP samples were prepared using RNA from one CLIP 
procedure each; from half a mouse forebrain each. At the end of the Illumina 
small RNA protocol a size range of 90 bp to 150 bp of final PCR product was 
purified; this size range contains both Ago2 associated miRNA and mRNA target 
sites. The second set of samples consisted of four Ago2-Flag and two control 
 126 
samples, which each was prepared from a pool of RNA from four CLIP 
procedures; amounting to CLIP RNA from two mouse forebrains per sample. At 
the end of the Illumina small RNA protocol for this set of samples the products 
were purified in a band from 110 to 150 bp containing Ago2 associated mRNA 
target sites. All mRNA target site containing samples were Solexa sequenced 
Prepared samples were amplified onto flowcells using the Illumina cluster 
station per manufacturer protocol and sequenced on the Illumina GAIIx platform 
76 cycles. Raw sequencing data was processed using the onboard SCS/RTA 
software yielding 76 bp reads. 
 
Data pre-processing and miRNA detection 
Sequence reads were filtered to remove low quality reads, using a minimum 
average cutoff quality score of 25 over 75% of the read. Sequence reads were 
trimmed of any identifiable adapter sequence using several variations on the 
adapter sequence supplied by Illumina. Reads not containing adapters were 
aligned to the mm9 genome build using bowtie, allowing for 3 mismatches for 76 
bp reads. The last 8 bases were not used during the alignment to allow for 
incomplete adapter trimming. For those reads that did not align initially were 3’ 
trimmed and re-aligned at 36 bp allowing 2 mismatches to account for lower 
quality sequence at the 3’ end of the read. Adapter-trimmed reads from long 
libraries were aligned allowing for 2 mismatches. 
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Detection of mRNA target sites clusters: 
For the downstream analysis of mRNA targets, clusters of Ago2-Flag reads were 
detected using a filtering approach described here. To reduce contributions of 
nonspecifically binding RNA species from cluster detection any Ago2-Flag read 
within 30 bp of overlapping reads from the grouped control samples were 
discarded. Then only reads occurring in at least two filtered Ago2-Flag samples 
were kept and 30 nucleotides of genomic sequence was added to each end of the 
filtered reads. These reads were filtered to only retain clusters composed of 
minimum of 10 overlapping reads. Genomic distribution of clusters was 
examined by use of Cis-regulatory Element Annotation System (CEAS). Filtered 
clusters that strand-specifically intersect RefSeq 3’UTR plus 1 kb additional 
downstream genomic sequence (3’UTR) were used for 6mer analysis and 
genome-wide target site analysis . 
 
6mer enrichment analysis 
The abundance of all possible 6mer sequences was found using the perl script 
countkmer.pl (by Marco Blanchette) in moderately filtered clusters that strand 
specifically intersect 3’UTR regions. The same was done for all refSeq 3’UTR 
genomic sequences for use as background (normalized to contain the same total 
number of 6mers as detected in clusters). The z-score and chi-square p-value 
were calculated for all 6mer sequences enriched in clusters over refSeq 3’UTR 
genomic sequences. The z-score was calculated for each 6mer by subtracting the 
abundance in refSeq (background) from the abundance in clusters and 
subsequently dividing by the standard deviation of the background subtracted 
abundance of all 6mers. The value of the z-score conveys how far away from the 
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mean a given 6mer is in units of standard deviation of the entire collection of 
6mers.  
 
Genome-wide target site analysis: 
Bowtie was used to map all sequences complementary to miR-128 6mer seed to 
mouse genome mm9, allowing no mismatches. Intersection was done with the 
moderately filtered clusters in 3’UTR, generating genome browser tracks with 
predicted miRNA targeted sites. All genome browser tracks were converted into 
tables listing all genes detected with their predicted miRNA targeted sites 
 
RNA Preparation  
Mice were anaesthesized under CO2 and the cortex, hippocampus and striatum 
were rapidly dissected and frozen in liquid nitrogen until further processing. 
RNA extraction from frozen samples was performed using the 
TriZol/Chloroform technique according to manufacturer’s instructions 
(Invitrogen Corporation, Carlsbad, CA). After extraction, RNA was precipitated 
overnight at -80C in isopropanol with 0.15M sodium acetate, washed once with 
70% ethanol, air-dried and resuspended in RNase-free water.   To address 
differences in miR-128 expression in D1-MSNs versus D2-MSNs, 
immunoprepitation of tagged Ago2 protein from the striatum of Drd1-Cre; 
Rosa26-Ago2-Flag (n=4) and Drd2-Cre; Rosa26-Ago2-Flag (n=4) mice was 
followed by isolation of associated RNA as described above. 
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Purification of mRNA for D1-TRAP-profiling 
Drd1a-cre; miR128-2fl/fl mutants are crossed to mice carrying D1-MSN specific 
expression of eGFP tagged ribosome protein L10 (135). Procedure for striatal 
dissection and tissue processing for microarray analysis are as previously 
detailed (135).  
 
Gene Expression Analysis by microarray. 
Trizol-Chloroform extracted total RNA was further purified using an RNeasy 
Micro Kit (Qiagen, Valencia, CA) with in-column DNase digestion, and analysed 
using Nanodrop 1000 spectrophotometer (Thermo Scientific, Wilmington, DE) 
and a Bioanalyzer (Agilent Technologies, Santa Clara, CA) to assess RNA 
quantity and quality. Purified RNA was amplified and processed according to 
the Affymetrix cDNA synthesis kit. Affymetrix Mouse Genome 430 2.0 arrays 
were used in all experiments. Mouse Genome 430 2.0 arrays were scanned using 
the GeneChip Scanner 3000 (Affymetrix, Santa Clara, CA) and globally scaled to 
150 using the Affymetrix GeneChip operating software (GCOS v1.4). GeneChip 
files (.cel) were imported into Genespring GX 11 (Agilent Technologies, Santa 
Clara, CA) processed with GC-RMA algorithm and expression values on each 
chip were normalized to median of all samples. Samples were compared to 
similarly processed littermate control samples (n=4 each). All probes with 
differential expression p-value<0.05, 2-way ANOVA (genotype) for TRAP-
profiling were considered significantly changed in the absence of miR-128. 
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Absolute Quantification of mature miR-128 in the brain  
Quantitative RT-PCR was used to estimate copy number of miR-128 in brain 
samples (Taqman, Life Technologies). Standard curve was generated using 
synthetic single stranded RNA oligonucleotides of the mature miR-128 sequence 
with 5’-phosphate and 3'-hydroxyl modification as synthetic miRNAs (IDT). RT-
PCR and quantitative real-time PCR were performed on duplicate serial 
dilutions of the mimics according to manufacturer’s protocol and cycle count 
was plotted against concentration of microRNA mimic. Mimic concentration was 
converted to copies per cell using the assumption of ~15pg of total extracted 
RNA per cell. All brain sample quantification used 15ng of total RNA input 
(~1000 cells) and mean cycle count values from miR-128 quantification of wild 
type striatum or cortex samples (n=16 and n=13 respectively) were used to 
estimate copy number per cell in each sample type.  
 
Taqman Quantitative RT-PCR for miRNA and mRNA analysis 
Relative expression levels of mature miRNAs and mRNAs were measured by 
Taqman assays using total extracted RNA from brain samples, according to 
manufacturer’s protocol (Life Technologies, Carlsbad, CA). The purified RNA 
samples were assayed by qRT-PCR for relative gene expression using pre-
designed Taqman gene expression assays from Applied Biosystems (ABI) as 
recommended by the manufacture. The following pre-designed Taqman gene 
expression assays from Applied Biosystems (ABI) were used: miR128 (Assay ID 
002216), sno135 (Assay ID 001230), miR124a (Assay ID 001182). Cycle counts for 
miRNA quantification were normalized to snoRNA135 unless otherwise 
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indicated, cycle counts for mRNA quantification were normalized to GAPDH. 
Relative expression (ΔCt) and quantification (RQ=2-ΔΔC) for each mRNA were 
calculated using RQ Manager Software and the ΔΔCt method.  
 
Luciferase Reporter Assay 
Luciferase reporter assays were performed to measure repression of candidate 
target 3’UTR by miR-128 mimics. MicroRNA 3’UTR target reporter plasmids 
(Genecopoiea, MD) contained full length 3’UTR inserts cloned downstream of a  
Firefly Luciferase gene. Control plasmids containing no inserts were used for  
comparison. Reporter plasmids contained Renila Luciferase gene as reporter for  
transfection efficiency. All plasmids were verified by sequencing and restriction 
digests. Reporter or control plasmids were co-transfected into confluent 
Neuro2A cells grown in 24-well culture plates with either no mimics,  control 
scrambled miR124 mimics or miR128 mimics at indicated concentrations 
(Dharmacon, Thermo Fisher Scientific, USA). Cells were harvested and lysed 24 
hour after transfection and cell lysate was assayed for Firefly luciferase and 
Renilla Luciferase activity using Dual-Luciferase Reporter assay kit (Promega, 
Wisconsin, USA) according to manufacturer’s instructions. Firefly Luciferase  
activity was normalized to Renilla Luciferase activity for each culture well and 
plotted as activity relative to control transfections with no mimics added. At least 
3 biological replicates were performed consisting of 3 technical replicates each.  
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Protein Quantification 
Mice were anaesthesized under CO2 and the cortex, hippocampus and striatum 
were rapidly dissected and frozen in liquid nitrogen until further processing. 
Samples were sonicated on ice in 1% SDS solution supplemented with protease 
inhibitor (Roche, Switzerland) and phosphatase inhibitor, and boiled for 10 
minutes. Protein concentration was determined using BCA protein assay kit 
(ThermoFisherScientific, USA) according to the manufacturer’s instructions. 
Protein samples were diluted in equal volume of 2X loading buffer (Invitrogen) 
and supplemented with DTT to a final concentration of 200mM (Sigma). 25ug of 
protein samples were separated on 4-12% Bis-tris precast denaturing gels 
(Invitrogen) and blotted onto PVDF membranes and blocked with 5% milk in 
TBS- 0.1% Tween (TBST) solution for 1 hour at room temperature. Membranes 
were probed with primary antibodies diluted in 5% milk-TBST solution 
overnight at 4C.  Membranes were washed and probed with horseradish-
peroxidase conjugated anti-mouse or anti-rabbit IgG secondary antibody for 1 
hour at room temperature. Membranes were developed using enhanced 
chemiluminescence substrate (PerkinElmer, USA) and exposed on BioMax film 
(Kodak, USA). Exposed films were scanned and protein bands quantified using 
ImageJ Software (NIH, USA). Protein quantities were normalized using beta-
Actin, phosphoprotein levels normalized to total non-phosphorylated protein 
levels and all values plotted as relative to its control littermate sample. Primary 
antibodies used: total ERK1/2 (137F5), phosphoERK1/2 (Thr202/Tyr204), 
DARPP32 (19A3), phosphoDARPP32 (Thr34) (Cell Signaling, MA).   RCS (mouse 
monoclonal 6A, gift. A. Nairn), beta-Actin (Abcam), PEA15a (H80) (Santa Cruz), 
D4ertd22e (Atlas),  
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FACS analysis 
Nuclei from mouse striatum were purified as previously described for cerebellar 
mouse nuclei (189) including minor changes.  Briefly, brains from decapitated 
mice were frozen for 5 seconds in liquid nitrogen and the striata dissected on ice 
and homogenized with a glass dounce homogenizer using first a loose then tight 
pestle (Kimble Chase; 1984-10002).  The cell homogenate was fixed with a final 
concentration of 1% paraformaldehyde for 12 minutes at room temperature and 
the reaction quenched with 0.125 M Glycine for 5 minutes at room temperature.  
To isolate the striatal nuclei, the fixed homogenate was spun through a 29% 
iodixanol cushion and the nuclei pellet resuspended in blocking buffer (0.25 M 
sucrose, 25 mM KCl, 5 mM MgCl2, 20 mM Tricine pH 7.8, 1% Donkey Serum and 
0.01% Tween-20) supplemented with 0.15 mM spermine, 0.5 mM spermidine, 
EDTA‐free protease inhibitor cocktail (Roche; 11836170001) and phosphatase 
inhibitor cocktail II (Calbiochem; 524625).  For FACS analysis, nuclei were 
blocked overnight at 4ºC and stained for 1 hour at 4ºC using antibodies against 
Histone H3 phosphorylation of Serine 10 (H3S10) conjugated to an Alexa555 
fluorophore (Cell Signaling Technology; 3475S). FACS analysis was carried out 
on a BD LSR instrument.  Single nuclei were selected by gating on FSC and SSC 
singlets.  For the analysis of activated D1 nuclei, gating by two dimensional 
criteria was used.  First, the presence of a GFP signal above the background was 
used to determine D1 nuclei from other striatal nuclei.  Second, activated D1 
nuclei were determined by a higher Alexa555 signal than Saline-injected D1 
nuclei.  Percentages of various nuclei populations were analyzed using Prism 
software. 
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Brain slice preparation 
Para-sagittal brain slices (275 µm) were obtained from 3-5 month old male and 
female wild type and mutant mice following procedures approved by the 
Northwestern University Animal Care and Use Committee. The mice were 
anesthetized with a mixture of ketamine (50 mg kg–1) and xylazine (4.5 mg kg–1) 
and perfused transcardially with 5–10 ml ice-cold artificial cerebrospinal fluid 
(ACSF) containing (in mM): 124 NaCl, 3 KCl, 1 CaCl2, 1.5 MgCl2, 26 NaHCO3, 1 
NaH2PO4, and 16.66 glucose, continuously bubbled with carbogen (95% O2 and 
5% CO2). The slices were then transferred to a holding chamber where they were 
incubated in ACSF containing (in mM) 2 CaCl2, 1 MgCl2, at 35ºC for 60 min, after 
which they were stored at room temperature until recording.  
 
Electrophysiology 
Patch pipettes were pulled from thick-walled borosilicate glass on a Sutter P-97 
puller. Pipette resistance was typically 3–5 MΩ when filled with recording 
solution. For studies involving bAP propagation the internal recording solution 
contained (in mM): 135 KMeSO4, 5 KCl, 10 HEPES, 2 ATP-Mg2+, 0.5 GTP-Na+, 5 
phosphocreatine-tris; 5 phosphocreatine-Na+, 0.1 spermine; pH was adjusted to 
7.25 with NaOH and osmolarity to 270–280 mOsm l–1.  For Ca2+ imaging 
experiments, the recording solution also contained 200 µM Fluo-4 
pentapotassium salt and 50 µM Alexa Fluor 568 hydrazide Na+ salt (Invitrogen).  
For voltage clamp studies the recording solution contained (in mM): 120 
CsMeSO3, 5 NaCl, 10 TEA-Cl (tetraethylammonium-Cl), 10 HEPES, 5 Qx-314, 4 
ATP-Mg2, 0.3 GTP-Na, 0.2 Fluo 4 pentapotassium salt and 0.05 Alexa Fluor 568 
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hydrazide Na+ salt (Invitrogen), pH 7.25, 270-280 mOsm-1.  Slices were 
transferred to a submersion-style recording chamber mounted on an Olympus 
BX51 upright, fixed-stage microscope and continuously perfused with carbogen-
bubbled ACSF. Electrophysiological recordings were obtained with a Multiclamp 
700B amplifier.  Stimulation and display were obtained as previously described 
(128) using the custom-written shareware package WinFluor (John Dempster, 
Strathclyde University, Glasgow, Scotland, UK), which automates and 
synchronizes the two-photon imaging and electrophysiological protocols.  The 
amplifier bridge circuit was adjusted to compensate for serial resistance and 
continuously monitored during recordings.  Analysis of mEPSCs was performed 
in the presence of 1 µM TTX using MiniAnalysis software (Synaptosoft).   
 
2-photon laser scanning microscopy (2PLSM) and Ca2+ imaging 
2PLSM and Ca2+ imaging were performed as previously described (128).  
Striatonigral SPNs were identified by somatic eGFP two-photon excited 
fluorescence using an Ultima Laser Scanning Microscope system (Prairie 
Technologies). A DODT contrast detector system was used to provide a bright-
field transmission image in registration with the fluorescent images. The green 
GFP signals (490–560 nm) were acquired using 810 nm excitation (Verdi/Mira 
laser). SPNs were patched using video microscopy with a Hitachi CCD camera 
and an Olympus 60X/0.9 NA lens.  Alexa 568 fluorescence was used for 
visualization of cell bodies, dendrites, and spines. Following patch rupture, the 
internal solution was allowed to equilibrate for 15–20 minutes before imaging.  
Whole cell maximum projection images of the soma and dendrites were acquired 
with 0.36 µm2 pixels with 10 µs pixel dwell time; ~80 images taken with 1 µm 
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focal steps.  High magnification maximum projection images of dendrites were 
acquired with 0.072 µm2 pixels with 10 µm pixel dwell time; ~20 images taken 
with 0.5 µm focal steps.   
 
Spine density was calculated from maximum projection images of dendritic 
segments ~100-120 µm from the soma, as previously described (Chan et al., 
2012).  Spines were manually counted and normalized to the length of the 
corresponding dendrite.  
 
Single bAPs were generated by injecting somatic current pulses (2 nA, 2 ms).  
Dendritic changes in Ca2+ were measured as ∆F/Fo via line scans, where Fo is the 
average green fluorescence before the bAP.   Peak ∆F/Fo values were obtained 
from the average of 6 consecutive trials and calculated by a single exponential fit 
of the Ca2+ transient decay.  Green fluorescent line scan signals were acquired at 
6 ms per line and 512 pixels per line with 0.08 µm pixels and 10 µs pixel dwell 
time. The laser-scanned images were acquired with 810 nm light pulsed at 90 
MHz (~250 fs pulse duration). Power attenuation was achieved with two Pockels 
cells electro-optic modulators (models 350–80 and 350–50, Con Optics, Danbury, 
CT). The two cells were aligned in series to provide an enhanced modulation 
range for fine control of the excitation dose (0.1% steps over four decades). The 
line scan was started 200 ms before the stimulation protocol and continued 4 s 
after the stimulation to obtain the background fluorescence and to record the 
decay of the optical signal after stimulation. To reduce photo-damage and photo-
bleaching, the laser was fully attenuated using the second Pockels cell at all times 
during the scan except for the period directly flanking the bAP burst.   
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Dendritic line scans were acquired from proximal (~50 µm from soma) and distal 
(~100-120 µm from soma) dendritic regions for each cell.  bAP attenuation was 
calculated by normalizing distal Ca2+ transient peaks to the maximum proximal 
Ca2+ transient per cell.  
 
Drugs  
Mice were injected intraperitoneally with volume of 10X body weight. 
D1-receptor agonist SKF81297 (Taconic) is diluted from stock (10mg/ml in 
DMSO) with 0.9% saline to indicated concentration. MEK inhibitor SL327 
(Taconic) is diluted from stock (diluted in DMSO) with 30% DMSO/Saline to 
indicated concentration. 
 
Behavior Analyses 
All behavior tests have been performed on 4- to 16-week-old mutants and their 
respective age and sex-matched littermate controls. All behavior tests were 
conducted between 7 AM and 7 PM. 
 
Open-Field Analysis   
Locomotion and exploratory behavior was measured using the open field 
analysis in novel environment (clear plexiglass chamber 40 X 40 X 30 cm ). 
Activity was quantified by computer-operated Photobeam activity system 
(Accuscan Instruments, Columbia, OH). Mice were recorded for total distance 
moved in the whole arena, distance moved in center vs periphery of arena 
(thigmotaxis) and number of vertical episodes (rearing). Data was collected in 5 
or 10 min intervals over 60-100 min test sessions.  
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Home Cage Seizure Monitoring  
Animals were housed in clear plexiglass chambers with pre-installed cameras 
(Phenotyper, Noldus Information Technology), and provided with food and 
water ad libitum. Continuous 24-hour video recordings of mice were taken. 
Video recordings were manually scored for severity, duration and frequency of 
seizures. To constitute a recorded tonic-clonic seizures, mice must cease all 
normal activity such as walking, sniffing or grooming, adopt a rigid posture with 
arched back and progress to repeated rearing and falling. A large majority of 
tonic clonic seizure episodes progressed to a further stage with rapid running 
and bouncing behavior, although this was not required for inclusion as tonic-
clonic seizure.  
 
Chemically-induced seizures. 
Mice were injected i.p. with kainic acid (30 mg/kg in saline) or picrotoxin (3 
mg/kg in saline) and placed in chambers in isolation and observed for 60 min. 
All injected animals rapidly enter period of immobility (Stage 1). Animals were 
observed for the time of onset of tonic clonic seizures characterized by repeated 
rearing and falling followed by running and bouncing or constant limb 
movements if postural control is lost. 
 
Survival Analysis 
Date of sacrifice or death in the home cage is recorded for mutants and cage mate 
controls, and plotted as Kaplan-Meier survival curves and compared using log-
rank tests. 
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6-OHDA lesion 
Mice were anaesthesized with ketamine/xylazine. Stereotactic injection of 6-
OHDA (3.5mg/ml in 0.02% ascorbic acid) 2X2ul in left striatum (ML=-2.1 
AP=+1.0 DV=-3.4; ML=-2.3 AP=+0.3 DV=-3.4). and vehicle injection  2X2ul in 
right striatum (ML=+2.1 AP=+1.0 DV=-3.4; ML=+2.3 AP=+0.3 DV=-3.4). Mice 
were single housed for 3 weeks after surgery to allow for recovery before 
behavioral assays. 
 
Rotational behavior  
Rotational behavior in lesioned mice was assayed by an experimenter blind to 
the genotypes for 2X2min interval 5 min after injection of cocaine (10 mg/kg). 
Net contralateral rotations are average of 4 readings taken over 2 days. After 3 
days, the same behavior was recorded in response to D1-agonist SKF81297 (5 
mg/kg). 
 
Cocaine-conditioned place preference 
Mice were exposed to the 3-chamber experimental set-up (Med Associates)  for 
15 minutes, a day before the first test to allow mice to acclimatize to testing 
conditions. During testing phases, mice were placed in the center chamer and 
allowed free access to all chambers. Chamber entries and duration spent in each 
chamber was measured by the automated system. During daily conditioning, 
two pairings were performed. In the first pairing, mice were injected with either 
saline or cocaine (15mg/kg) and allowed to explore a pre-selected pairing 
chamber (left or right) for 15 minutes. 4 hours later, the second pairing is 
performed in which mice were injected with the other solution and placed in the 
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other chamber for 15 minutes. The duration of the time spent in each chamber 
during the test phases were recorded. 
 
Novel object recognition task 
Test was performed in a clear plexiglass chamber. Mice were allowed exposed to 
the empty chamber one day before tests to allow mice to acclimatize. During the 
training phase, the mice were first allowed to explore the empty chamber for 5 
minutes.Then the mice are removed and 2 identical training objects were placed 
in opposite sides of the chamber before the mice were re-introduced into the 
chamber. Time spent in exploration of each object was manually assessed by an 
experimenter blinded to the genotypes of the mice. Exploration behavior was 
characterized by sniffing directed at the object or forelimb contact with the 
object. Mice were removed into a new cage for 1 hour until the first test phase. 
One training object and one novel object was placed in the same positions and 
mice was re-introduced and exploratory behavior was assessed as before. Object 
placements were randomized for each mouse to preclude position-dependent 
effects. Second test phase was performed 24 hour after the training phase using a 
new "novel" object and one training object. 
 
Statistical analysis 
Analyses were performed using either Microsoft Excel or Graphpad Prism 
software.
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